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ABSTRACT  
Background  
The prevalence of Alzheimer’s Disease (AD) is greater in women compared to men, but the reasons 
for this remain unknown. This sex difference has been widely neglected in experimental studies using 
transgenic mouse models of AD.  
Objective 
Here, we studied behaviour and molecular pathology of 5-month-old 5XFAD mice, which express 
mutated human amyloid precursor protein and presenilin-1 on a C57BL/6J background, vs. their wild-
type littermate controls, to compared both sex- and genotype-dependent differences.  
Methods 
A novel behavioural paradigm was utilised (OF-NO-SI), comprising activity measures (Open Field, OF) 
arena, followed by Novel Object exploration (NO) and Social Interaction (SI) of a sex-matched 
conspecific. Each segment consisted of two repeated trials to assess between-trial habituation. 
Subsequently, brain pathology (amyloid load, stress response and inflammation markers, synaptic 
integrity, trophic support) was assessed using qPCR and Western blotting.  
Results 
Female 5XFAD mice had higher levels of human APP and beta-amyloid (Aβ) and heightened 
inflammation vs males. These markers correlated with hyperactivity observed in both sexes, yet only 
female 5XFAD mice presented with deficits in object and social exploration. Male animals had higher 
expression of stress markers and neurotrophic factors irrespective of genotype, this correlated with 
cognitive performance. 
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Conclusion 
The impact of sex on AD-relevant phenotypes is in line with human data and emphasises the necessity 
of appropriate study design and reporting. Differential molecular profiles observed in male vs. female 
mice offer insights into possible protective mechanisms, and hence treatment strategies. 
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INTRODUCTION 
As the most common cause of dementia, Alzheimer’s Disease (AD) is a progressive debilitating 
neurodegenerative disease currently affecting > 500,000 people in the UK. Dementia is characterised 
by progressive cognitive deficits, memory loss and non-cognitive behavioural changes in, for example, 
activity, sleep, and mood [1].  
The incidence for AD appears to be greater in women compared to men even when corrected for 
demographic differences [2,3]; AD-associated hippocampal atrophy and cognitive decline are also 
more prominent in female patients [4]. This was traditionally attributed to the longer lifespan of 
women, but recent research has indicated that biological differences (for example in chromosomes, 
hormones or epigenetics) may be just as important  [5–7].  Even though human studies have provided 
some insight into these sex differences in AD patients, sex differences in experimental models of AD 
continue to produce varying and sometimes conflicting results, especially when trying to associate 
behavioural and molecular pathologies. For example, female 3xTg-AD mice (with transgenes for APP 
(amyloid precursor protein, Swedish mutation), tau (P301L mutation), and PSEN-1 (presenilin-1, 
M146V mutation) displayed greater spatial cognitive deficits, neuroinflammation and A burden 
relative to males of the same age [8,9]. On the other hand, sexual dimorphism noted in P301S Tau 
transgenic animals indicated that male mice displayed significant changes in a composite behavioural 
phenotype as well as in tau phosphorylation. Females presented with impairments only in specific 
behavioural tests, such as Morris water maze and open field  and had  lower expression of some 
inflammatory markers [10]. Conversely, no sex differences in gene expression were observed in other 
models such as our knock-in PLB1triple mice (with transgenes for APP, tau and PSEN1) or the PLB4 
(knock-in of human BACE1 (β-secretase)) mice [11,12]. 
Neuropathologically, AD is characterised by the cleavage and subsequent processing of two proteins, 
i.e. APP and the microtubule-associated protein tau [13]. APP is preferentially cleaved by BACE1, 
leading to the loss of secreted APPα in favour of beta-amyloid (Aβ) [14], which aggregates into 
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oligomers and fibrils causing the formation of plaques. It is generally assumed that metabolites of APP 
(and tau) are toxic and cause neuroinflammation, abnormal stress of the endoplasmic reticulum (ER), 
and dysregulation of neurotrophic factors, jointly leading to neurodegeneration [15].  
Chronic neuroinflammation is characterised by an increase in activated astrocytes and resident 
microglia, but also by the activation of the NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) 
inflammasome, and these appear to trace disease progression [16,17].  Particularly relevant here are 
immunoreactive Iba-1 (Ionized calcium binding adaptor molecule 1) and GFAP (Glial Fibrillary Acidic 
Protein) as markers for activated microglia and astrocytes respectively, which occur in close proximity 
to A deposits [18–20]. NLRP3, on the other hand, has shown promise as an experimental therapeutic 
target [21,22]. There is also increasing evidence from human studies indicating that sex differences in 
systemic inflammation are linked to greater AD pathology [23]. Similarly, protein aggregation in AD 
has been associated with the chronic unfolded protein response (UPR), typical for prolonged stress 
resulting in apoptosis and synaptic loss and observed to be activated in patients with AD [15,24,25].  
This pathway is connected to amyloid pathology since tunicamycin-induced ER stress can cause 
overproduction of A peptides in cell lines [26] while conversely, A is known to increase multiple ER 
stress markers [27].  Repair and protective mechanisms in neurones are in place to counteract these 
damaging events, such as brain-derived neurotrophic factor (BDNF), tropomyosin-related kinase B 
(TrkB), and cAMP response element-binding protein (CREB), and these are all compromised by A 
accumulation  [28,29]. Higher BDNF serum levels were associated with slower cognitive decline in a 
cohort of human patients [30] and more recently, female carriers of specific polymorphisms in 
neurotrophic genes were found to have 93% higher risk of developing AD compared to male non-
carriers suggesting that sex-dependent effects associated with neurotrophic factor can modify the risk 
of AD [31]. These studies are however, limited and require further investigation.  
Overall, how cellular stress and inflammation relate to toxic proteins such as A, and more specifically, 
whether interactions are affected by sex, still remains elusive.  Here, we employed one of the most 
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commonly used murine models of amyloid pathology, the 5X Familial AD mouse (5XFAD), which 
expresses the three human APP (hAPP) gene mutations alongside two human presenilin-1 (hPSEN1) 
mutations [32]. From the three lines originally generated, Tg7699 (now termed 5XFAD) expressed the 
highest levels of transgenic APP and displayed early (at 2 months) and aggressive amyloid pathology, 
as well as elevated inflammatory markers (GFAP) and reduced levels of synaptic markers 
(synaptophysin and PSD-95) by 9 months of age [32]. Surprisingly, an investigation into ER stress 
markers in a mixed-sex cohort in this model failed to identify genotype differences [33].  However, 
conditional delivery of BDNF from astrocytes rescued memory impairments and prevented synaptic 
loss in 5XFAD mice [34].   
The impact of sex on phenotypes in 5XFAD mice is still controversial.  While Sadleir and co-
workers [35] recorded heightened levels of Aβ42 in female transgenic animals relative to their age-
matched male counterparts, a transcriptomic and proteomic analysis of the hippocampi of 4 month 
old 5XFAD animals did not reveal any sex biases for the development of amyloid pathology or the 
inflammation marker GFAP [36]. However, female 5XFAD mice showed heightened gliosis in both 
cortex and hippocampus aged 13 months relative to males [37] and sustained microglial activation 
from 4 to 9 months of age [38]. 
The data on the behavioural profile of 5XFAD mice is more conflicting. Male transgenic mice 
presented with working and short-term memory deficits aged 4-5 months, but there was no overall 
change in locomotor activity [20, but see 28 for contrasting results]. However, deficits in activity were 
reported in specific motor tasks from 9 months, but this was not sex specific [39]. Ambulation in the 
open field or Y-maze was also reduced at this age in females only [40], but this phenotype was lost in 
older cohorts [37,41]. Data from 12-month old male 5XFAD mice suggested intact memory during 
object recognition tasks in an open field and Y-maze while age-matched females displayed clear 
impairments [37]. The authors suggested that the study design and complexity of the task are 
determinants for the discrimination of sex-specific phenotypes. Studies into social deficits, while 
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limited, have indicated abnormal social recognition at 9 months of age (mixed sex; [42] as well as 
decreased exploration of conspecifics in an age-dependent manner in females only [43]). Differences 
in test parameters as well as appropriate study design choices of controls [44] have likely contributed 
to the reported discrepancies. Finally, many studies do not report the sex of animals used [45]. And it 
is frequently unclear whether 5XFAD animals used were on a C57BL6/J background, and whether the 
recessive retinal degradation allele Pde6brd1 or the muscular dystrophy gene Dysfim found in the 
original SJL background were eliminated [39].  
Here, we used our novel OF-NO-SI paradigm, which combines elements of the open field, novel object 
exploration and social interaction [46].  Its reliance on multiple neurotransmitters makes it an ideal 
candidate task to explore genotype- and sex-related phenotypes, and to confirm whether such 
phenotypes are consistent with previously reported data from 5XFAD mice. In vivo testing was 
followed by a detailed within-subject post-mortem tissue analysis to measure amyloid pathology, 
inflammatory, synaptic, ER stress and neurotrophic markers, and explore correlations between 
behavioural and molecular endpoints.  
Our data suggest distinct behavioural and molecular phenotypes in female vs. male 5XFAD littermates, 
with only the former displaying subtle behavioural anomalies that correlated with heightened levels 
of beta-amyloid and inflammation, while the latter showed an upregulation of potentially 
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MATERIAL AND METHODS 
This work was conducted according to the ARRIVE guidelines 2.0 for reporting animal research [47] 
and the recommendations of the EQIPD (European Quality in Preclinical Data) WP3 (Work Package 3) 
study group for the internal validity in the design, conduct and analysis of preclinical biomedical 
experiments involving laboratory animals [48].   
Animals and experimental conditions 
5XFAD (B6.Cg-Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/Mmjax) mice on BL/6J background 
were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA: stock number 34848-JAX) and 
bred and maintained on-site at the University of Aberdeen by backcrossing to C57BL6/J mice. 
Genotypes were confirmed from ear-biopsies to identify transgenic (5XFAD) animals expressing both 
APP and PSEN-1 and wildtype (WT) genes, carried out by Transnetyx Inc. (Cordova, USA). A total of 40 
five-month-old mice (male WT, n=10, female WT, n=10; male 5XFAD, n=10; female 5XFAD, n=10) were 
utilised. Animals were group-housed together in conventional type 3 polycarbonate stock cages 
(Tecniplast, Italy) with a maximum of 7-8 animals per cage, separated by sex, and maintained on a 12-
hour day-night cycle (lights on 7am, simulated dusk/dawn 30 mins) in temperature- (20-22°C) and 
humidity- (60-65%) controlled holding facilities with ad libitum access to both food (Special Diet 
Services, Witham, UK) and water.  Enrichment was provided by paper strips, cardboard tubes, and 
corncob as bedding (DBM Scotland Ltd).  Behavioural testing took place on weekdays during the light 
period (09:00-16:00) in a separate testing room.  Animals were tail-handled multiple times a week so 
as to reduce anxiety prior to testing. Three age- and sex-matched C57BL/6J mice (either male or 
female) served as stranger mice for social interaction trials and were kept in a separate holding room, 
under the same housing conditions. The experimenter was blinded to the genotype of the subject and 
testing order was randomised using a random number generator (www.random.org).  No power 
calculation was available; estimates were based on previous research [42]. All procedures were 
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approved by local ethical review, a UK Home Office project licence and complied with the EU directive 
63/2010E and the UK Animal (Scientific Procedures) Act 1986.  
Open Field-Novel Object-Social Interaction (OF-NO-SI) Paradigm 
As described in Yeap et al., the OF-NO-SI paradigm [46] offers multiple within-subject readouts of 
behaviour, including activity and habituation, as well as interaction and recognition of an inanimate 
object vs. a conspecific. Experiments were conducted in a white circular Perspex arena of 50cm 
diameter, illuminated by white LED lights (average light intensity recorded in the arena =160.6 lux) 
facing directly downwards onto the arena. Animals were tracked using an overhead camera (Sony) 
connected to the ANY-maze video and activity tracking software (v 6.0, Ugo Basile, Comero, Italy) 
complemented by manual observations by the experimenter for urination and defecation during 
different trials but no differences were observed (data not reported) [46]. Between trials, the 
apparatus was cleaned with non-alcohol, fragrance-free wipes between trials to remove odour cues. 
Prior to experimentation, mice were individually housed in transport cages (conventional shoe box 
cages (Tecniplast, Italy)) with fresh bedding, water but no food) and habituated to the testing room 
for 45 minutes. Average temperature and humidity of the testing arena were recorded as 20.5°C and 
60.5%, respectively. Arena definitions included a wall zone (5cm from the outer wall of the arena) and 
an interaction zone (centric 5cm wide ring around the cylinder (Fig. 1C)). The protocol followed exactly 
the one reported by Yeap et al. [42] and consisted of three test stages, each with 2 trials of 10 mins, 
separated by an inter-trial interval (ITI) of 15 minutes, during which the test animals were returned to 
their transport cages (Fig. 1A and 1B). The first stage consisted of two open field trials (OF); in the first 
(OF1) the animal was placed randomly along the wall of the empty arena and allowed to explore freely 
for 10 minutes. This was repeated for the second open field trial (OF2) after the 15-minute ITI. OF 
trials served as a habituation component to the remainder of the task components.  
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In the second stage, a novel object (cylindrical wire-mesh cage: 8 cm in diameter, 20 cm tall) was 
introduced into the centre of the arena. Again, two trials (NO1, NO2) were administered, all other 
parameters were identical to the OF trials. In the third social interaction (SI) stage, a stranger mouse 
was introduced into the cylinder; all other parameters were identical to OF and NO stages. It is 
acknowledged that as the stranger mouse was in the cylinder, this interaction was more akin to 
approach behaviours, however the term SI has been retained to maintain similarity with the paradigm 
name described by Yeap and colleagues. Animals were run in pairs so that one animal was tested while 
the other had its ITI (Fig. 1B).   
Behavioural data analyses 
The  distribution of the animal in the arena was visualised by generating heat maps [46] using MatLab 
R2017a (MathWorks, Massachusetts, United States), which illustrated average location preference 
during each trial for one representative animal per genotype and sex (closest to group average values).  
Primary behaviours (activity measured as distance moved, time spent in predefined zones and number 
of visits to selected zones) were recorded and analysed using ANY-maze behavioural tracking software 
(Ugo Basile, IT) tracking the centre of gravity at 10Hz sampling rate. One female (5XFAD, no. 371) had 
to be excluded from analysis because of a tracking error.  
Data are presented as parameters of interest averaged over the 10-minute duration of each trial.  
Total path length (in m) in 10 minutes of each trial during OF was recorded as a measure of 
locomotor activity while time (s) in wall zone served as a proxy for anxiety related behaviours.  To 
establish effective habituation to the open field, data for OF trials are presented as distance moved 
per minute (see Supplementary Information).  Time (in s) spent in the interaction zone (<5 cm from 
the cylindrical mesh cage; Fig. 1C) while ‘directed exploration’ (in s) was recorded when the animal’s 
head was directed at the object/conspecific while in the interaction zone during NO and SI phases. 
These were utilised as proxies for the exploration of the object/stranger. The number of visits to the 
interaction zone was also recorded as a proxy of purposeful approaches to the object / stranger.  
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Statistical analysis and graphs were prepared using Prism (V 8.0; GraphPad; USA). Data were averaged 
per genotype and sex and are represented as mean ±SD for each trial. Normality of data was confirmed 
using the Shapiro-Wilk normality test, while outliers were determined using the method of Grubbs (3- 
standard deviation from mean). This led to the exclusion of one female WT (no. 384) which showed 
abnormal hyperactivity during all phases of the paradigm.  For all analyses, alpha was set to 5% with 
values less than p<0.09 being termed as marginally significant [49]. 
Main effects and interactions were assessed for each stage using a three-way analysis of variance 
(ANOVA) with sex (male or female), genotype (5XFAD vs WT) and trial (repeated measures, RM) as 
factors, followed by selected post-hoc Bonferroni’s comparisons (see Supplementary information for 
full details of post-hoc tests). Within-trial habituation (indicated by declining values over the 10 
minutes during trial 1) and between-trial habituation (indicated by higher activity during trial 1 vs trial 
2) was probed using a 2-way ANOVA for each group with trial and time as repeated measures for 
specifically the OF stage (see Supplementary information). Familiarity indices were also calculated for 
NO and SI stages [(Time in/Number of visits to/Directed exploration in interaction zone in trial 1) - 
(Time in/number of visits to/Directed exploration in interaction zone in trial 2)]/(Total time in/total 
visits to  zone) to evaluate memory formed during trial 1; positive values constitute recall. For the 
familiarity indices during NO and SI, a one-sample t-test against a hypothetical chance value of 0 was 
employed within each genotype of each sex to observe if there was a significant change in either time 
spent in zone/number of visits/directed exploration between trial 1 and trial 2. Group effects were 
determined using a two-way ANOVA. To observe differences between object vs social stimulus, 
familiarity indices for NO vs SI for time in zone, number of visits and directed exploration were also 
compared using a three-way ANOVA with sex, genotype and trial (NO vs SI, repeated measures) as 
factors. All data relating to familiarity indices are presented in the Supplementary Material.  
 
 
Sil et al., 2021: Sex difference in 5X mice 
Brain extraction and lysate preparation 
Mice utilised in the OF-NO-SI experiment (~5.5-month-old at time of brain collection) were terminally 
anaesthetised with Euthatal (Merial Animal Health Ltd., Lyon, France) intraperitoneally and 
transcardially perfused with 0.9% heparinised saline. Extracted hemi-brains were snap-frozen in liquid 
nitrogen and stored in -80°C until use. Samples were processed as described previously [50] to obtain 
soluble and insoluble fractions. In brief, brain tissue (~80mg) was homogenised in ~1:10 (w/v) Igepal 
(Sigma, Dorset, UK) based non-denaturing, non-ionic lysis buffer (in mM: 20 HEPES, 150 NaCl, 1% 
Igepal, 0.1 EDTA, pH= 7.6) with inhibitors for protease and phosphatase (PhosStop) (Roche Life 
Science, Burgess Hill, UK). Samples were centrifuged (13,000g, 4 °C for 20 mins); the supernatant 
constituted the soluble fraction. The pellet was homogenised twice in Igepal lysis buffer (1ml) via 
repeated aspiration with a 1ml pipette tip, briefly vortexed and then centrifuged (14,000 rpm, 20 
mins), and then resuspended in 1:1 (w/v) 70% formic acid at 4 °C for overnight agitation. The formic 
acid fraction was then spun (18000g, 4 °C for 20 mins) and the resultant supernatant formed the 
insoluble fraction. Before use, the insoluble fraction was mixed with 4 volumes of neutralising buffer 
(2M Tris + 2M NaH2PO4).  
Immuno-blotting 
Western and dot blots were performed as previously described [50]. Protein concentration for the 
soluble fraction was adjusted (3µg/ml) following bicinchoninic acid assay measurement (BCA, Sigma-
Aldrich, Poole, UK) and dilution in lysis buffer. A set volume of neutralised samples for the insoluble 
fraction was utilised as protein concentration evaluation using BCA is not possible due to the strong 
reducing action of formic acid [51].  
For Western blotting, all samples (soluble and insoluble) were mixed with lithium dodecyl sulphate 
(LDS, Thermo Fisher, Paisley, UK) and 15 mM dithiothreitol (DTT, Sigma), and heated for 10 mins at 
70 °C (apart from samples meant for detection of amyloid) and run on 4–12% Bis-Tris precast gels 
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(Nupage, Thermo Fisher Scientific) in MOPS buffer (Nupage, Thermo Fisher Scientific) for 45 mins (or 
MES buffer (Nupage Thermo Fisher Scientific) for 35 min in case of Iba-1 only) at 200V constant 
voltage. For detection of full-length APP (fAPP) and monomeric Aβ, samples were mixed only with LDS 
and loaded onto the precast gels in MES buffer without an additional heating step. For these amyloid 
markers and Iba-1, transferring was done onto 0.2 µm nitrocellulose membranes via the iBlot system 
(Nupage, Thermo Fisher Scientific), followed by microwaving for 3 mins in PBS (phosphate buffered 
saline (Sigma Aldrich, UK) for detection of low molecular weight proteins; for all other proteins, 
standard transfer conditions were applied onto 0.45 µm nitrocellulose membranes.  
For the selective detection of amyloid-beta (A) via dot blots [50], samples were dotted directly onto 
0.2 µm nitrocellulose membranes (5 µl of 2 µg/µl per dot for the soluble fraction and 5 µl of 
neutralised insoluble fraction samples). No DTT, LDS or heating steps were involved. Following this, 
washing of all blots was carried out in 0.05% Tween-20 (Sigma) containing Tris- buffered saline (TBST; 
in mM: 50 Trizma base, 150 NaCl, pH= 7.6). All membranes were then blocked for 1 hour at room 
temperature in TBST containing 5% milk powder. Primary antibodies in 5% bovine serum albumin 
(BSA, Sigma Aldrich, UK) containing TBST were then added to the membranes for overnight incubation 
at 4 °C (refer to Table 1 for a list of antibodies utilised). Secondary antibodies (as appropriate) were 
added for 1 hour at room temperature (goat anti- rabbit/ goat anti- mouse, IgG, HRP conjugated; 
Merck Millipore (1:5000)) before visualisation using enhanced chemiluminescence (1.25 mM luminol, 
30 µM coumaric acid, 0.015% H2O2). A Vilber- Fusion- SL camera (Vilber, Eberhardzell, Germany) and 
iBright™ FL1000 Imaging System camera (Invitrogen™, ThermoFisher Scientific) were utilised to 
capture immunoreactivity at 16bit for analysis. Membranes were then processed for total protein 
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qPCR 
Total RNA was extracted from snap-frozen hemi-brain tissue using TRI Reagent (Ambion, Warrington, 
UK) as per the protocol of the manufacturer. Bioline cDNA synthesis kit (Bioline, London, UK) was 
utilised to synthesize cDNA from 1 μg of total RNA. Amplification of genes of interest was achieved by 
quantitative polymerase chain reaction (PCR) in a Roche LightCycler® 480 System (Roche Diagnostics, 
Burgess Hill, UK) using GoTaq qPCR Master Mix (Promega, Southampton, UK).  Relative gene 
expression was calculated using the comparative Ct method (2−δδCt)[52]. A comprehensive list of all 
primer sequences utilised can be found in Table 2. Normalisation of the data utilised the geometric 
mean of three of the most stable reference genes (Y-Whaz, NoNo, 18S, GAPDH or BetaActin). As 
human APP (hAPP) and PSEN-1 (hPSEN-1) were not detectable in WT animals, a ratio of the Ct values 
of most stable reference gene on the plate and the gene of interest was carried out to obtain gene 
expression data. 
Analysis of molecular data 
Quantification for Western and dot blots was performed as area under the curve (AUC) using ImageJ 
(Ver. 1.51, NIH, USA) software, and adjusted to total protein as per Coomassie or Ponceau. Fold change 
was then calculated relative to female WT controls (the WT control group was selected randomly). 
Statistical analysis was carried out using Prism (V8.0, GraphPad). Normality was assessed using a 
Shapiro-Wilk normality test and outliers were determined using the Grubb’s test. Unless otherwise 
stated, data sets were analysed using a regular two-way ANOVA to measure the effect of genotype 
and sex with selected post-hoc paired comparisons using Bonferroni correction. As it was the intention 
of the authors to specifically examine potential sex and genotypic differences from the outset of the 
study, post-hoc analysis without prior significant interaction using pre-planned contrasts were carried 
out. For gene expression data of hAPP and hPSEN1 in the transgenic animals, an unpaired parametric 
t-test was carried to observe differences between sexes. Data are presented as bar charts with scatter 
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(mean +SD) and alpha was set to 5%.  Only significant terms (p<0.05) and marginally significant values 
(p<0.09) are given for clarity.   
Correlations 
Correlational analysis was carried out between behavioural and molecular markers of interest. For the 
behavioural markers, total activity in OF, NO and SI, as well as time in wall zone during OF, time in 
zone, number of visits, directed exploration during NO and SI and NO were utilised. All markers 
underwent Z-transformation within each group (combined♀+♂ 5XFAD, ♀5XFAD, ♂5XFAD, ♀+♂ WT, 
♀WT, ♂WT) followed by Pearson’s correlation analyses after confirmation of Gaussian distribution of 
datasets. Correlations are displayed in the form of a heat plot matrix with red indicating negative 
correlations and blue indicating positive ones with values of individual correlational coefficients and 
their significant/marginally significant p-values (dark green to light green for p-values between 0.001-
0.06) represented in the Supplementary material. For all comparisons in the Supplementary, 
significance was set at p<0.05. 
RESULTS 
OF-NO-SI Behavioural Experiments 
Normal habituation amidst heightened activity in 5XFAD mice 
Exploration of the open field was recorded as activity, defined as total distance moved, during the 
entire length of OF1 or OF2. A 3-way ANOVA with sex, genotype and trial (RM) as factors revealed a 
very strong effect of genotype (F (1,34) = 18.93); p<0.0001), due to higher locomotor activity in 5XFAD 
animals compared to WT (Fig. 2A). A strong effect of trial (F (1,34) = 182.0; p<0.0001) confirmed lower 
activity during OF2 compared to OF1, i.e. habituation between trials (see also Table S2 for individual 
post-hoc trial-wise comparisons for all groups). And a significant three-way interaction finally 
indicated that genotypic differences during OF were dependent upon both, sex and trial (F (1,34) 
=15.06; p<0.0001) with male 5XFAD mice having the highest level of activity during OF1 and female 
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5XFAD animals having greater activity than their own WT during OF2 (see Table S2 for post-hoc 
Bonferroni’s tests).  Many other post-hoc comparisons also yielded significances (see Suppl. Table S2 
for more details).   
To observe if both within- and between-trial habituation occurred during the OF trials, 2-way ANOVAs 
for each sex and genotype group were conducted (binned per minute over OF1 or OF2, with trial and 
time as repeated measures). Results suggested both intact within- and between-trial habituation for 
all groups, yet the effect was (based on significances obtained) smallest for 5XFAD female mice (see 
Supplementary Figure S1 including statistics). Hence, 5XFAD mice differed in terms of activity, and to 
a lesser extent in the degree of habituation, in a sex-dependent manner. 
Heightened thigmotaxic behaviour in the open field in female 5XFAD mice 
Thigmotaxis, assessed as wall hugging (time in wall zone), was also affected by sex (F (1, 34) = 5.406; 
p<0.05, 3-way ANOVA, Fig. 2B). A strong effect of trial (OF2 vs. OF1), i.e. a decline between trial 1 and 
trial 2, was also noted (F (1, 34) = 46.92; p<0.0001). In contrast to activity, there was no overall 
genotype for thigmotaxis between 5XFAD and WT animals, yet inspection of data and an interaction 
obtained (sex x genotype: F (1, 34) = 6.190; p<0.05) indicated genotypic differences were present due 
to female 5XFAD animals displaying increased thigmotaxis, compared to their WT counterparts 
(p=0.025) and male 5XFAD (p=0.002, see Table S2 for details of post-hoc tests). The representative 
heatmaps which indicated location preference for each trial for each genotype and sex also displayed 
higher occupancy of female 5XFAD mice in the wall zone (see heatmaps in Fig. 2C) especially during 
OF1.  
Exploration of a novel object (NO) in 5XFAD mice 
We next introduced an object (wire mesh cylinder) into the centre of the open field arena and 
returned test subjects for two further trials. Since global path length is not the best indicator for 
habituation during NO trials [46], object exploration and familiarity was indexed by the time the 
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animal spent in the interaction zone (Fig. 1C), directed exploration of the novel object and the number 
of visits to this zone. 
No gross overall differences between 5XFAD animals and controls were observed for contact time in 
the interaction zone (Fig. 3A), but a main effect of sex emerged (F (1, 34) = 8.759; p<0.05), such that 
female animals spent less time in the zone compared to males. The lowest time in zone was recorded 
for female 5XFAD (Fig. 3A), in line with a marginally significant p-value for sex by genotype interaction 
(F (1, 34) = 3.980; p=0.0541), with post-hoc tests confirming differences between male and female 
5XFAD animals (female vs male 5XFAD, p=0.0002, see Table S2). A strong overall effect of trial was 
also detected (F (1, 34) = 15.14; p<0.0001), although the horizontal nature of the graph for the female 
5XFAD animals indicated a potential lack of between-trial habituation for the parameter time in zone 
in these animals. Gross sex differences were identified with regards to directed exploration (Fig 3C), 
as female animals spent less time with the object overall (F (1, 34) = 4.156, p=0.049), accompanied by 
a strong trial-wise decline (F (1,34) = 232.2, p<0.0001).  As for the number of visits (Fig. 3B), 5XFAD 
mice entered the interaction zone more frequently than WT animals, as indicated by a strong effect 
of genotype (F (1,34) = 11.15; p<0.001). A robust trial-wise decrease in the number of visits was also 
observed in all groups (F (1,34) =232.2; p<0.0001).  
5XFAD animals continued to display higher overall activity during the NO stage (genotype: F (1, 34) = 
8.004; p=0.0078, see Supplementary Fig. S2 and Table S2), which was also dependent on the trial (trial: 
F (1, 34) = 317.9; p<0.0001). Heatmaps for representative animals of each group display both reduced 
time in the zone around the cylinder for female 5XFAD compared to other groups during NO1 and 
visibly reduced activity levels during NO2 vs NO1 for most groups (Fig. 3D).  
The familiarity indices for the NO parameters (Supplementary Fig. S3 A, B, C) meanwhile did not report 
any gross group differences, although differences between male and female animals were detected 
for time in zone and directed exploration (one-sample t-test against chance =0), such that only male 
animals of both genotypes had intact indices (see Fig S3). 
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Exploration during social interaction trials (SI) in 5XFAD mice 
In the third and final test stage, we placed a sex-matched conspecific as a stranger into the cylinder 
and again recorded time in zone, directed exploration of the conspecific and entries into the 
interaction zone.  During SI, a genotype difference for time in zone was obtained (F (1, 34) = 7.386; 
p<0.05); this was especially apparent for female 5XFAD animals during SI1 with the lowest contact 
time (Fig. 4A). A strong effect of trial was also observed (F (1, 34) = 18.69; p<0.0001) indicating 
between-trial habituation for all cohorts. Like NO, directed exploration of the conspecific during SI 
indicated a sex difference between male and female animals (F (1, 34) = 9.303, p = 0.004) with female 
animals spending less time directly interacting with the stranger (Fig. 4C). A trial-wise decline in this 
parameter was also noted (F (1, 34) = 22.33; p<0.0001). 
A difference between 5XFAD and WT animals (F (1, 34) = 6.299; p<0.05) was also obtained for the 
number of visits to the interaction zone (Fig. 4B) during SI trials; female 5XFAD mice visited the social 
partner more frequently than their WT counterparts and male 5XFAD animals during SI (genotype x 
sex interaction: p<0.001; female 5XFAD vs. female WT: p= 0.0001; female vs male 5XFAD: p=0.01, 
Table S2). Together with contact time and directed exploration data, this suggests that female 5XFAD 
mice entered the zone more frequently, but visits were much shorter.  
During SI, the overall activity was not different between 5XFAD and WT animals (Supplementary Fig. 
S2).  However, marginally significant p-values for an effect of sex and related interactions emerged (F 
(1, 34) = 3.393; p=0.07, sex x genotype interaction: (F (1,34) =3.383; p=0.08; sex x trial interaction: F 
(1, 34) = 6.665; p=0.0143), indicating that male and female animals behaved differently in specific 
trials (SI1: Female vs. Male, p=0.02, Table S2). This difference between the sexes is further reflected 
in the heatmaps, which confirm that the female group (especially the female 5XFAD during NO1) spent 
less time in the vicinity of the stranger mouse (Fig. 4D). 
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Once again, as during NO, no gross group differences were observed for the familiarity indices for time 
in zone/directed exploration/number of visits during SI using a two-way ANOVA (Supplementary Fig. 
S3 D, E, F). When using a one-sample t-test for each group against chance (=0), female 5XFAD animals 
had a non-significant SI index  for time in zone (Fig. S3D) (t=1.14, n=9, p>0.05), while all other groups 
displayed positive, significant indices (female WT: t=2.734, n=9, male 5XFAD: t=2.693, n=10, male WT: 
t=2.658, n=10; all p<0.05) for this parameter.  
Interestingly, there was no trial effect for number of visits (trial: p>0.05) and a lack of significant 
familiarity index for the number of visits to the zone (p>0.05) (Fig. S3E) for all groups. This was further 
supported by a very significant effect of trial (F (1, 34) = 64.83; p<0.0001) when the familiarity index 
for number of visits (all groups) were compared between the NO and SI segments (3-way ANOVA with 
sex, genotype and trial, repeated measures: NO vs SI; Figure S3I). This can likely be attributed to the 
stronger social vs inanimate stimulus [46] and provides further evidence that the OF-NO-SI paradigm 
can efficiently report differences between object and stranger exploration.  
Collectively, the 5XFAD cohort, irrespective of sex, was robustly hyperactive during the OF-NO-SI 
paradigm and exhibited more frequent visits to the interaction zone during NO and SI trials. Gross 
object / stranger exploration differences between genotypes were detected for number of visits (NO 
and SI) and time in zone (SI only), while other readouts support the existence of a strong sex difference 
between male and female animals. Female subjects overall spent less time interacting directly with 
the object/conspecific compared to male ones. More specifically, female 5XFAD subjects spent less 
time in the zone with the object/stranger, showed no between-trial habituation for time in zone during 
both NO/SI, but entered the interaction zone more frequently during the SI trials compared to all other 
groups. Table 3 summarises all the 3-way ANOVAs results of the OF-NO-SI test for all groups.  
 
 
Sil et al., 2021: Sex difference in 5X mice 
Post-mortem molecular analysis 
Heightened gene expression of hAPP, but not hPSEN-1 in female 5XFAD mice 
In line with the behavioural phenotype, 5XFAD female mice had significantly higher hAPP gene 
expression compared to males (t=3.125; p<0.05, +3% cf males, n=6; Fig. 5A). By contrast, gene 
expression of hPSEN1 was not different between sexes (Fig. 5B). As stated earlier, no hAPP and hPSEN1 
were detected in WT animals.  
Heightened levels of APP and its metabolites in female 5XFAD animals in soluble fraction 
Full-length APP (fAPP) was determined by western blotting using the 6E10 antibody in both the soluble 
fraction (Fig. 6A) and  insoluble fraction (Fig. 6B); results confirmed highly significant effects of 
genotype (soluble: F (1,27) =912.4, p<0.0001; insoluble: F (1,25) = 145.6, p <0.0001), sex (soluble: F 
(1,27) = 111.2, p<0.0001; insoluble: F (1,25) = 6.671, p=0.0160) as well as interactions (soluble:  F (1,27) 
= 111.2, p<0.0001; insoluble: F(1, 25) = 4.698, p=0.039). Compared to very low levels in WT mice 
(soluble and insoluble: male WT vs male 5XFAD; female WT vs female 5XFAD: all p<0.0001), 
significantly elevated amounts of fAPP were found in female 5XFAD animals, also compared to male 
5XFAD and particularly in the soluble fraction (+100% for soluble, +45% for insoluble; soluble: 
p<0.0001; insoluble: p=0.01; female 5XFAD vs male 5XFAD) (Fig. 6A and 6B).  
Dot-blot analysis of A protein was carried out using MOAB-2 antibody, which does not cross-react 
with APP or non-A metabolites and has lower affinity for A40 compared to the more neurotoxic 
A42 (see [50]).  In the soluble fraction (Fig. 7B), data mirrored results obtained with 6E10, in that we 
found a very strong effect of genotype (F (1, 28) = 98.41, p<0.0001), sex (F (1,28) = 17.07, p=0.0003) 
and a genotype x sex interaction (F (1, 28) = 12.73, p=0.0013), with higher levels of A in female 5XFAD 
mice compared to their male counterparts (+108% cf male 5XFAD; p<0.0001) and very low levels in 
WT animals (male WT vs 5XFAD: p=0.0007, female WT vs 5XFAD: p<0.0001). An effect of genotype 
was also observed in the insoluble fraction (Fig. 7C; (F (1, 25) = 12.85, p=0.0014; female WT vs 
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5XFAD=p=0.003, post-test) even though values were generally lower and more variable, which may 
explain why the effect of sex did not reach statistical significance (Fig. 7C).  
Overall, both gene and protein analyses confirmed hAPP expression and processing in 5XFAD mice, 
with a higher gene and protein load for female vs male 5XFAD mice confirming previous reports [35]. 
Protein levels were even more dramatically increased in females than suggested by gene expression, 
indicative of additional factors influencing pathology build-up. 
Increased inflammation in female 5XFAD mice 
Western blot analysis of the astrocyte marker GFAP (both bands averaged for quantification) indicated 
a significant overall effect of genotype (F (1,25) = 13.07, p=0.001), yet significantly higher levels of 
GFAP were only found in female 5XFAD animals compared to female WT (+150%, p=0.047; Fig. 8B). 
Immunoblot analysis of the activated microglial marker, Iba-1 (Fig. 8C), indicated a strong significant 
effect of genotype (F (1,26) = 17.53, p=0.003) but also sex (F (1,26) =16.95, p=0.003). Post-hoc planned 
contrasts confirmed that female 5XFAD mice had higher levels compared to female WT (+50%, 
p=0.002), but also vs. male 5XFAD mice (+50%, p=0.0018). A lack of specificity observed while trying 
various NLRP3 antibodies was replaced by utilising a qPCR-based gene expression approach to analyse 
this inflammasomal marker (Fig. 8D).  It also indicated a significant effect of genotype (F (1,17) = 22.08, 
p=0.0002) and sex (F (1,17) = 8.956, p=0.008) with female 5XFAD animals yielding higher expression 
levels of NLRP3 compared to male 5XFAD (+64%, p=0.03) and to their respective WT (+130%, p=0.001) 
using post-hoc planned contrasts. Here, no genotype effect was observed for the male mice. 
No changes in synaptic markers in 5XFAD mice 
Protein levels of the presynaptic marker synaptophysin revealed no overall difference between 
genotypes; however, a sex effect was detected (F (1, 25) = 6.488, p=0.017; Fig. 9B), due to higher levels 
observed in females in both genotypes, with post-hoc contrasts revealing only a marginally significant 
p-value for differences between male and female 5XFAD animals (p=0.08). Immunoblot analysis of the 
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post-synaptic marker PSD-95 (Postsynaptic density protein 95; Fig. 9C), on the other hand, indicated 
an effect of genotype (F (1,26) = 5.174, p=0.03), with increased levels in transgenic mice. Post-hoc 
contrasts indicated only marginally significant differences between female 5XFAD animals and their 
WTs (p=0.08). It therefore appears that despite the high levels of amyloid pathology, a gross reduction 
of synaptic markers could not be confirmed in both sexes of 5XFAD mice.  
Sex-associated differences in specific arms of the ER pathway 
Gene expression analyses of different markers from the ER stress pathway was conducted next (Fig. 
10). The ER is the most essential component of protein folding and secretion and is affectedly 
adversely in AD neurons. In the event of chronic ER stress in AD, the chaperone, BiP (Binding 
immunoglobulin Protein), which supports folding of proteins, can cause the activation of the UPR 
signalling and transcription factors, IRE1 (inositol requiring enzyme), ATF6 (activated transcription 
factor 6), CHOP (C/EBP Homologous protein) and total XBP (XBPt or X-box protein, a further key 
transcription factor involved in ER degradation) which forms spliced XBPs (XBPs). Ultimately, this can 
trigger apoptosis and worsen neurodegeneration in AD [15].  
Following on from the above tissue results, gross genotype effects were only observed for 2 markers: 
CHOP (F (1,20) =5.96, p=0.024; Fig. 10B) and total XBP (XBPt) (F (1,19) = 5, p=0.037; Fig. 10F). However, 
while male 5XFAD animals had higher expression of CHOP (p=0.046, Bonferroni's post-hoc; +50%), 
they had lower expression of XBPt (p=0.028; -25%) compared to male WT.  
In addition, sex-dependent differences were detected for the ER chaperone BiP (F (1, 19) = 82.14, 
p<0.0001; Fig. 10A), as well as the global chaperone marker Hsp70 (Fig. 10B; F (1, 19) = 30.31, 
p<0.0001).  CHOP, a transcription factor involved in ER-associated apoptosis regulation (F (1, 20) = 
64.34, p<0.0001; Fig. 10C) followed the same pattern.  
In stark contrast to amyloid and inflammation markers, male 5XFAD animals had higher expression of 
BiP (p<0.0001; +100%), CHOP (p<0.0001; +100%) and Hsp70 (p=0.002; +120%; Fig. 10A-C) compared 
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to female transgenic animals. For both CHOP and BiP, male WTs also showed higher expression 
compared to the female WTs (p<0.0001, p=0.0015, respectively).  
An interaction of sex x genotype was noted for gene expression of ATF6 (F (1,18) =11, p=0.0038; Fig 
10D) which also reported an effect of sex (F (1, 18) = 7.524, p=0.0134). A matching pattern (interaction 
of sex and genotype) was also observed in the case of XBPt (F (1,19) =5.614, p=0.028, Fig. 10F).  For 
both ATF6 and XBPt, male WT animals had higher gene expression compared to both male 5XFAD 
(ATF6: p=0.009; +50%, for XBPt see above) and female WT (ATF6: p=0.003, +50%;  XBPt: p=0.039, 
+25%) animals. Neither the spliced variant of XBP (XBPs) nor the ratio of XBPs/XBPt displayed any 
effect of genotype or sex (Fig. 10G and 10H)).  
An unusual sex x genotype interaction was also uncovered for IRE1α (F (1,15)=7.254, p=0.016, Fig. 
10E), alongside a marginally significant p-value for a genotype effect (p=0.07), with female 5XFAD 
animals reporting very low expression (cf WT: p=0.026, -91%; , cf male 5XFAD: p=0.08, -78%). No such 
genotypic difference was observed for males. Overall, ER stress markers by and large yielded sex-
specific and UPR-arm specific alterations, also causing a number of sex-dependent genotype effects.  
Heightened levels of neurotrophic markers in male mice 
The downregulation of neurotrophic factors such as BDNF and its TrkB receptor, as well as CREB, which 
controls the transcription of BDNF, have all been reported in AD, and considered as targets for 
treatment [53].  At the same time, sex differences in the expression of neurotrophic factors have also 
been well documented [54], making these protective entities interesting and relevant markers for the 
present study.  
Analysis of the gene expression of BDNF (Fig. 11A) did not yield any reliable differences between the 
sexes or genotypes (but note marginally significant value for genotype: F (1, 18) =3.611, p=0.076). For 
CREB and TrkB, a significant effect of sex was seen (F (1,16) = 46.46, p<0.0001 and F (1,19) = 10.89, 
p=0.004, respectively). Post-hoc analysis of CREB (Fig. 11B) suggested higher expression in males cf. 
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females for both genotypes (p=0.0028, +66% for 5XFAD; p=0.0005, +95% for WT), while for TrkB (Fig. 
11C), male WTs yielded higher levels compared to male 5XFAD (p=0.048, +36%) and female WT 
animals (p=0.0006, +50%). It therefore seems that, like ER stress markers, male mice express enhanced 
levels of neurotrophic and potentially protective factors, particularly CREB.  
Table 4 summarises all the 2-way ANOVAs results of the molecular analysis for all groups while 
Supplementary Figure S4 shows examples of Coomassie loading controls. 
Correlational analyses 
To make advancements regarding our understanding of links between pathways and phenotypes, and 
to explore connections between cognition, AD pathology and related cellular markers, we next 
conducted a multi-factorial correlation analysis in both WT and 5XFAD animals (Fig. 12). The greatest 
power for this analysis is achieved by combination of data sets derived from male and female cohorts.  
Additional sex-specific heatmaps have been provided (Fig. S6 A, B, C, D) are for comparison only; we 
did not analyse those further to avoid type 1 and type 2 errors. Particular weight is placed on the 
emergence of clusters comparing i) behavioural proxies; ii) cellular proxies including pathological and 
inflammatory, but also stress and trophic markers; and iii) behavioural x cellular proxies and their 
differences between genotypes. Supplementary Figure S5 also shows both the WT and 5XFAD 
(combined sex groups) with the values for the correlational coefficients (Pearson’s r value, left) placed 
inside each matrix as well as the p-values less than 0.06 (right). While it is our intention is to 
concentrate on clusters of interest, rather than probing or overinterpreting individual significances, 
plots of the r values alongside the p-values for the combined sex groups have been provided in the 
appendix (Fig. S5) to aid readers who might be interested in understanding individual significances. By 
and large, all the correlations discussed below, were also found to be significant.  
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Correlations between behavioural proxies 
Overall, only modest correlations between the different behavioural proxies were apparent, and this 
was similar in WT and 5XFAD cohorts.  The strongest positive correlations (blue fields in Fig. 12A) were 
between activity measures of all stages of the task and directed exploration during SI and NO stages, 
suggesting that WT animals with heightened locomotor activity also interacted more with the 
object/social partners. Interestingly, the nature of this correlation was reversed in case of the 5XFAD 
mice where activity measures were negatively correlated with directed exploration (red fields in Fig. 
12B).  Another interesting find was that total time in the wall zone was found to be negatively 
correlated to directed exploration during NO and SI, only in the 5XFAD animals, suggesting that 
investigation of the stimulus (object/stranger) could be linked to anxiety-like behaviours in a negative 
fashion, only in the transgenic animals. In extension to our previous work using this paradigm [42], 
there was no correlation between the overall activity during OF and any other stage of testing in WT 
mice (Fig. 12A); by contrast, ambulatory activity correlated positively between all stages of testing in 
5XFAD mice (blue squares in first row, Fig. 12D) strengthening our argument of the predominant 
activity-related phenotype in this AD model.   
Correlations between cellular markers 
Heatmaps differ between genotypes for molecules associated with cellular pathology.  This is mainly 
due to the specific expression of human APP and the resulting amyloid species detected in 5XFAD 
mice, and which are absent in WT. Nevertheless, some clear clusters arose from the comparisons, 
more clearly seen in 5XFAD tissue. Correlations were globally positive between amyloid, inflammatory 
and synaptic markers in 5XFAD brains (Fig. 12D), some of them highly significant (dark blue squares) 
clearly underlining their relationships, especially on the background of tissue stress caused by amyloid 
levels. This was not as clear-cut in WT mice, a more varied pattern between mildly positive (faint blue) 
and mildly negative (faint red) correlations emerged. Similar for both genotypes, however, was the 
observation that stress and neurotrophic markers correlated strongly with each other, but negatively 
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with amyloid load, inflammation, and synaptic protein levels; some of these negative correlations 
were highly reliable (dark red squares).    
Correlations between behavioural proxies and pathological molecules 
Less homogenous were correlations between behavioural readouts and molecular endpoints.  An 
overall scattered and lightly coloured field showed few consistent correlations. Of interest, especially 
in light of the heightened activity found in 5XFAD mice, are positive correlations (blue squares) 
between activity/anxiety-related endpoints (time in wall zone, activity in NO and SI as well as visits to 
the object and social partner) and markers of amyloid, inflammation (Iba-1) and particularly 
presynaptic labelling, which were not found to the same degree in WT mice. Intriguingly, these 
correlations were even stronger in female 5XFAD mice (Fig. S6C) relative to males and may underpin 
the more pronounced phenotype in female transgenic animals. Additionally, especially apparent 
during SI, directed exploration time correlated negatively with pathological, inflammatory markers, 
and to a slightly stronger extent in 5XFAD mice (red raster Fig. 12B) compared to WT animals. A strong 
correlation also appeared between stress/neurotrophic markers and the global activity in the OF stage 
in WT mice (see dark blue raster, bottom of row 1, Fig. 12A).  This characteristic was less pronounced 
in 5XFAD tissue (Fig. 12B), mainly due to male mice (Fig. S6D), which showed negative correlations for 
these same rasters.  This would be in line with the proposed sex-specific protective or compensatory 
molecular response. Finally, both genotypes showed mainly positive correlations between directed 
exploration for NO/SI vs. cellular stress/trophic markers.  Given these offer a cognitive proxy of the 
subjects, this underlines the observation that no overt cognitive impairment was observed in 5XFAD 
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DISCUSSION 
Our results indicate distinct and dissociable sex-biases in development of both behavioural and 
molecular pathology in a cohort of 5-month-old 5XFAD mice. Mirroring what has been frequently 
observed in human studies, sex differences in transgenic mouse models of AD suggest a greater 
female-specific propensity for enhanced pathology and AD related cognitive phenotypes [8,37,55,56]. 
Overall, our data indicate that female transgenic 5XFAD animals present with hyperactivity, 
heightened anxiety, and some very subtle anomalies in object processing and social interaction in the 
OF-NO-SI paradigm, which were not found in males. They also exhibited higher levels of inflammatory 
markers and amyloid pathology, alongside reduced levels of protective neurotrophic or heat shock 
protein (HSP)-related markers. Furthermore, our correlation analyses in both WT and transgenic 
animals strongly suggests that the critical factors are not restricted to beta-amyloid itself, but rather 
dependent on the extent of the inflammatory reaction it causes, and how effective the compensatory 
strategies in the form of ER stress and neurotrophic factors are. 
During OF-NO-SI testing [46] multiple interesting within-subject readouts of activity and behaviour 
were obtained. 5XFAD animals exhibited higher locomotor activity compared to WT during the OF 
trials. Both intact within- and between-trial habituation of activity was observed across all groups; yet 
the degree of habituation was least pronounced in female 5XFAD mice compared to all other groups, 
suggesting that previously reported deficits in habituation to an open-field apparatus observed in 
(mixed-sex) 5XFAD cohorts [42,57] may also have been sex-specific. In partial agreement with our 
data, Leary et al. also reported that female 5XFAD animals (on a B6SJL background, unlike the C57BL/6 
background used here) travelled more than their respective WT (at 6 months of age), yet no such 
difference was observed in the male cohort [39]. The relationship between heightened ambulation 
and thigmotaxic (anxiety) behaviour was also increased in female 5XFAD animals compared to WT 
[40]. Hyperactivity is common in AD models and has also been detected in other APP over-expression 
lines [58], while for example low-expression knock-in transgenic mice showed lower activity at 5 
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months of age [12]. In general, a positive link between activity and cognitive phenotypes has been 
previously suggested [59], but hyperactivity can also lead to a more disrupted exploration pattern (as 
seen here in the female 5XFAD mice), and disturbed circadian activity, as often reported in transgenic 
AD lines (reviewed in [60]).  
We also observed that abnormalities in object exploration and social interaction behaviour are 
modulated by both genotype and sex. During NO, female 5XFAD animals spent less time in the zone 
around the object compared to male 5XFAD animals and overall female animals spent less time 
directly interacting with the object compared to males. Both, a lack of deficits in male [61] and in 
female 5XFAD mice have been noted previously for novel object exploration in 8-month old cohorts 
[62], but subtle sex-dependent phenotypes occurred in older subjects at 12 months [37]. In similar 
studies using TASTPM mice with mutant APPswe and PSEN1, both sexes displayed equal impairments 
on object exploration despite much higher Aβ load in females [63]. Although we here report a 
correlation of performance with amyloid load specifically affecting female 5XFAD mice, it appears that 
this relationship may be more complex and depend on the amyloid and non-amyloid factors [64] .  
Genotypic and sex differences during SI were more pronounced (vs NO), with female 5XFAD animals 
spending less time in zone compared to their controls and displaying lack of between-trial habituation 
as assessed by the SI familiarity index for time in zone. Additionally, female animals overall spent less 
time in directed exploration of the stranger mouse. To note, 12 month old transgenic 5XFAD female 
mice have previously exhibited less investigation of a novel stranger in a three-chamber apparatus as 
well as in a free social interaction test [43]. Given the greater anxiety-like phenotype in female 5XFAD 
animals, this could be indicative of novelty aversion due to heightened social anxiety. In other APP and 
PSEN1 mice, males at 6 months of age also displayed reduced sociability, again combined with 
hyperactivity [65]. Overall, transgenic mice with high levels of mutated APP and PSEN1 seem to 
consistently display changes in activity alongside reduced social interaction behaviours, with an 
additional dependency on sex.  
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We also found levels of both fAPP (soluble and insoluble fractions) and MOAB-2 reactive amyloid 
species (soluble fraction) to be higher in female 5XFAD animals compared to males as reported 
previously [35,36,66]. None of these studies, however, discriminated between full-length APP (and 
A) pathology in different fractions. Given the importance of soluble pre-fibrillar A species in tracking 
disease progression and decline in AD [50,51], our results further confirmed higher soluble amyloid 
load in females compared to males. This had previously been attributed to higher hAPP expression 
[35,36]; yet here, the increase in expression was very modest (+3% vs males), but amyloid-related 
protein levels were about double. Thus, gene expression alone is unlikely to fully account for the 
heightened amyloid accumulation. Moreover, no sex difference was observed for PSEN-1 gene 
expression, in line with a previous observation [36], though gamma-secretase activity may of course 
be higher in females. In any case, only one of the introduced transgenes is affected by sex, while the 
other is not. Congruent with the amyloid pathology, inflammatory markers GFAP and Iba-1 as well as 
NLRP3 were generally highest in the female 5XFAD group. The NLRP3 inflammasome has been 
implicated in AD and suggested to contribute to the pathology in APP/PSEN1 mice [67] by potentially 
acting as a sensor of Aβ, and by impairing microglial clearance and promoting inflammation [68,69]. 
One previous report in 5XFAD mice found higher levels of NLRP3 in transgenic animals compared to 
WT; however this did not reach statistical significance [70], potentially due to the use of only male 
mice.  
Our within-subject correlational analysis further confirmed the direct link between amyloid markers 
and inflammatory pathways in both control and 5XFAD mice, with stronger positive clusters observed 
in the transgenic animals.  Positive correlations between activity measures (and number of visits) 
during NO/SI and both soluble and insoluble amyloid markers as well as inflammatory markers (in 
form of Iba-1) predominantly in the transgenic group strongly suggest that high levels of amyloid are 
causally linked with the hyperactivity/anxiety phenotype. As a corollary, directed exploration during 
NO/SI correlated negatively with these pathology markers in 5XFAD mice and with time in zone during 
OF (anxiety-like phenotype).    
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Somewhat surprising was the unexpectedly higher (rather than lower) levels of the synaptic marker 
PSD-95 in 5XFAD mice. It is important to note that total protein levels were measured in our study 
rather than functional synapses (which would be more accurate). Changes in the level of synaptic 
markers depend largely on the region investigated  and may be a late-occurring event in the pathology 
of AD [25]. The increase in PSD-95 levels has also been observed in 5XFAD females by others [37], who 
attributed it to the loss of PSD-95 from apical dendrites and their movement and build-up in cell bodies 
[71], but this remains unexplained functionally. We here show that more positive correlations (blue) 
between PSD-95 and behavioural proxies in WT mice turn into no or negative correlations (red) in 
5XFAD subjects indicating that enhanced levels of PSD-95 is functionally detrimental.  By contrast, the 
presynaptic marker synaptophysin was unchanged in 5XFAD mice but correlations with activity-
dependent behavioural endpoints were generally positive, and with familiarity indices negative.  This 
is more like the pattern found for pathology/inflammation markers and confirms that both pre-and 
postsynaptic alterations may be responsible for functional changes recorded in the OF-NO-SI. While 
Maiti and colleagues have confirmed earlier reports of reduced synaptophysin and PSD-95 in cortex 
and hippocampus in 5XFAD mice from 4-12 months of age [32,72–74], others have published data 
reporting no differences in both markers [75]. However, most studies used exclusively males from a 
mixed B6/SJL background and control mice often were purchased from different vendors.    
ER stress and neurotrophic pathways in both the 5XFAD and WT groups revealed negative correlations 
with soluble and insoluble amyloid markers, indicating that reduced levels of chaperones (BiP, Hsp70 
and CHOP) and neurotrophic factors associate with amyloidosis. In fact, the elevated levels of some 
ER stress markers and neurotrophic factors observed in males may have provided protection against 
amyloid-induced toxicity. ER markers all exhibited strong sex-dependent effects with male animals 
displaying much higher levels compared to females. It has been demonstrated previously that 
expression of HSPA1 and HSPB1 (which constitute Hsp70) along with six other heat-shock proteins 
(HSPs) showed male-biased expression in the hippocampus of both 5XFAD and their C57BL/6 WT 
controls  at 4 months of age [36,76]. HSPs in general stabilise proteins and prevent misfolding [77], 
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while secreted Hsp70 masks Aβ in the extracellular space and suppresses neurotoxicity [78–80]. From 
this perspective, the higher expression of Hsp70 (and by extension BiP, a member of the Hsp70 family 
localised to the ER) in male mice may have offered some protection against Aβ accumulation and 
disease progression. Protein levels of CHOP were also increased in male APP/PSEN1 mice compared 
to their WTs [81], but our results are at odds with the lack of differences between genotypes and/or 
sex in protein levels of CHOP or BiP reported in 4-month 5XFAD mice previously [33].  Markers 
belonging to other arms of the UPR pathway such as ATF6 also displayed strong sex-related and 
genotypic differences (male WT>male 5XFAD). Investigations into the ATF6 pathway in transgenic 
models of AD remain limited [24] and to our knowledge this is the first report into its role in both sexes 
of the 5XFAD model. Of interest are also low levels of gene expression of IRE-1α in female 5XFAD 
animals and the lack of changes in expression of activated XBP (XBPs), which may reflect an age-
dependent change in the directionality of gene expression of these markers [82]. Strong sex-
dependent effects were also observed for neurotrophic markers like CREB and TrkB such that all male 
animals exhibited higher levels, yet here no genotype differences emerged. Similar to our 
observations, sex-related differences in CREB signalling (lower in females) have been described in 12 
month old 3xTg-AD mice [8]. No strong positive or negative correlations between behavioural and ER 
stress/trophic markers were revealed. All correlations were moderate to weak and the scatter in WT 
is similar to the scatter in 5XFAD mice. Finally, unique positive links were observed between HSP-
related ER stress markers/CREB and total activity during OF only in controls, which were absent in the 
5XFAD animals. Their relevance is not clear yet.   
Collectively, our results point towards sustained hyperactivity during all phases of the test in 5X mice, 
this correlated well with levels of pathological and inflammatory markers in 5XFAD mice. Phenotypes 
were more pronounced in females, in line with observations in human patients. Conversely, 
neurotrophic factors and ER chaperones support better cognitive performance and correlated with 
one another and were particularly prominent in male mice, possibly contributing to the alleviation of 
their phenotype.  
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Table 1 
Primary Antibodies utilised for Western blotting 
Primary antibody Epitope Dilution Supplier Product 
code 
PSD-95 aa 50-150 1:1000 Abcam (Cambridge, UK) ab18258 
Synaptophysin aa 250- 350 1:10000 Abcam ab32127 
IBA-1 C- terminus 1:1000 Wako (Eastleigh, UK) 019-19741 
GFAP Not reported 1:1000 Sigma G3893 
6e10 full length APP, monomeric Aβ 1:500 Biolegend  803001 
MOAB-2 Residues 1-4 of human amyloid 
beta peptide 40/42 
1:500 Biosensis M-1586-100 
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Table 2 













A list of all primers for both genes of interest as well as housekeeping genes utilised for qPCR with forward and reverse 





Marker Forward Reverse 
Primers for genes of interest 
hPSEN1 ACAGGTGCTATAAGGTCATCCA CAGATCAGGAGTGCAACAGTAAT 
hAPP ACTGGCTGAAGAAAGTGACAA ATCACCATCCTCATCGTCCTCG 
Hsp70 CAGCGAGGCTGACAAGAAGAA GGAGATGACCTCCTGGCACT 
Bip TTCAGCCAATTATCAGCAAACTCT TTTTCTGATGTATCCTCTTCACCAGT 
CREB CCCAAAAACGAAGGGAAATCCT CCTGGTGCATCAGAAGATAAGTC 
BDNF TCATACTTCGGTTGCATGAAGG ACACCTGGGTAGGCCAAGTT 
TRkB CCGCTAGGATTTGGTGTACTG CCGGGTCAACGCTGTTAGG 
ATF6 TTATCAGCATACAGCCTGCG CTTGGGACTTTGAGCCTCTG 
IRE-1a ACACTGCCTGAGACCTTGTTG GGAGCCCGTCCTCTTGCTA 
NLRP3 TGCTCTTCACTGCTATCAAGCCCT ACAAGCCTTTGCTCCAGACCCTAT 
XBPt AAGAACACGCTTGGGAATGG ACTCCCCTTGGCCTCCAC 
XBPs AAACAGAGTAGCAGCGCAGACTGC TCCTTCTGGGTAGACCTCTGGGAG 
CHOP CCACGGGACCTACTACGAGT ACGGCAAAGAGATCGGAGAGA 
Housekeeping Primers 
Nono GCCAGAATGAAGGCTTGACTAT TATCAGGGGGAAGATTGCCCA 
18S CTCTGTTCCGCCTAGTCCTG AATGAGCCATTCGCAGTTTC 
Y-whaz GAAAAGTTCTTGATCCCCAATGC TGTGACTGGTCCACAATTCCTT 
β-actin GATCTGGCACCACACACCTTC GGGGTGTTGAAGGTCTCAAA 
GAPDH TGACCACAGTCCATGCCATC GACGGACACATTGGGGGTAG 
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Table 3  
Summary of the behavioural OF-NO-SI results 
  









   
 
 
OF NO SI OF NO SI OF NO SI OF NO SI 
Trial **** **** **** **** *** *** N/A **** ns N/A **** **** 
Sex ns ns 0.07 * ** ns N/A ns ns N/A * ** 
Genotype *** ** ns ns ns *** N/A ** * N/A ns ns 
Trial x Sex 0.07 0.08 * ns ns ns N/A ns ns N/A ns ns 
Trial x Genotype ns 0.07 ns ns ns ns N/A ns ns N/A ns ns 
Sex x Genotype ns ns 0.08 * 0.05 ns N/A ns * N/A ns ns 
Trial x Sex x 
Genotype 
*** ns ns ns ns ns N/A ns ns N/A ns ns 
A summary table indicating all outcomes from a 3-way ANOVA with sex, genotype and trial (repeated measures) as factors 
for the OF (Open Field), NO (Novel Object) and SI (Social Interaction) segments of the OF-NO-SI paradigm for female and 
male 5XFAD and WT groups; significances are indicated as: ****=p <0.0001, ***= p<0.001, *=p<0.05, ns=not significant, 
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Table 4 
Summary of the molecular data 
Marker  Interaction Genotype Sex 
hAPP N/A N/A $ 
Sol. fAPP **** **** **** 
Insol. fAPP * **** * 
Sol. MOAB2 ** **** *** 
Insol. MOAB2 ns ** ns 
GFAP ns ** ns 
Iba-1 ns *** *** 
NLRP3 ns *** ** 
Synaptophysin ns ns * 
PSD-95 ns * ns 
BiP ns ns **** 
Hsp70 ns ns **** 
CHOP ns * **** 
ATF6 ** ns * 
IRE-1a * 0.06 ns 
XBPt * * ns 
XBPs ns ns ns 
BDNF ns 0.07 ns 
CREB ns ns *** 
TrkB ** ns ** 
A summary table indicating all outcomes from 2-way ANOVAs with sex and genotype as factors (or t-test in case of hAPP) for 
female and male 5XFAD and WT groups; significances are indicated as: ****=p <0.0001, ***= p<0.001, *=p<0.05, $= p<0.05 
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FIGURE LEGENDS 
Fig. 1: The OF-NO-SI experimental design: OF-NO-SI consists of a circular Perspex arena first used as 
an open field (OF) (A). Next, a cylinder is placed in the centre of the arena (novel object trials, NO) 
and finally a stranger mouse was introduced into the cylinder for social interaction trials (SI). (B) An 
overview summary of a single run of the OF-NO-SI experiment: green boxes depict inter-trial 
intervals (ITIs, 15-minutes), during which a second animal can be interspersed. (C) An outline of 
borders and zones used for the parameters examined:  The ‘wall zone’ (5cm from the outer wall) and 
‘interaction zone’ (5cm from the cylinder) are indicated. 
Fig 2: Activity measures for the open field trials (OF1 and OF2): Total distance travelled (in meters, 
m, per trial) during OF1 and OF2 trials for female and male 5XFAD vs WT mice (A), and total time 
spent in the thigmotaxis zone (in seconds, s) (B). Tables below graphs indicate statistically significant 
outcomes from a 3-way ANOVA with sex, genotype and trial (repeated measures) as factors. The 
pattern of exploratory behaviour for each group is also illustrated by representative heatmaps of 
one individual animal belonging to each group where bright colours indicate locations of frequent 
visits and darker colours indicate areas of rare approaches during OF1 and OF2 (C). Full statistical 
details can be found in Suppl. 1. All data are group means ±SD, Significances are indicated as: ****=p 
<0.0001, ***= p<0.001, *=p<0.05. 
Fig. 3: Exploration of the novel object during NO1 and NO2: Total time in the exploration zone (in 
seconds, s, per trial) during NO1 and NO2 for female and male 5XFAD vs WT mice (A), total time in 
directed exploration of the novel object (in seconds, s, per trial) (B) and total number of visits to this 
zone (C). Tables below graphs indicate statistically significant outcomes from a 3-way ANOVA with sex, 
genotype and trial (repeated measures) as factors. Representative heatmaps for exploratory activity 
during NO trials (D) clearly reveal how pattern of exploratory activity has shifted to the novel object 
zone during these trials (brighter colour concentrated around the centre where object was placed). 
Full statistical details can be found in Suppl. 1. Data are presented as group means ± SD with symbols 
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representing individuals; significances are indicated as: ****=p <0.0001, ***= p<0.001, *=p<0.05, 
ns=not significant.  
Fig. 4: Exploration of the conspecific during SI1 and SI2: Total time in the exploration zone (in seconds, 
s, per trial) during SI1 and SI2 for female and male 5XFAD vs WT mice (A) total time in directed 
exploration of the novel object (in seconds, s, per trial) (B) and total number of visits to the zone (C). 
Tables below graphs indicate statistically significant outcomes from a 3-way ANOVA with sex, 
genotype and trial (repeated measures) as factors. Heatmaps for exploratory activity (brighter colour 
marks more frequent visits) during SI trials (D) are displayed. Full statistical details can be found in 
Suppl. 1. Data are presented as group means ± SD, Significances are indicated as: ****=p <0.0001, 
***= p<0.001, *=p<0.05, ns=not significant.  
Fig. 5: Gene expression of hAPP, but not PSEN-1 is higher in female 5XFAD animals compared to 
male transgenic mice: Gene expression of hAPP (A) and PSEN-1 (B) for 5XFAD animals of both sexes 
are reported as ratio of Ct values of most stable reference gene on plate (y-whazz/b-actin) with gene 
of interest (hAPP/hPSEN-1). Data are illustrated as scatter plots with mean ±SD; significance is 
displayed as: *=p<0.05 (parametric t-test), n=6.  
Fig. 6: Greater levels of full-length APP in female 5XFAD mice in soluble and insoluble fractions: 
Representative images of western blots of both soluble and insoluble fractions probed with antibody 
6E10 for the detection of full-length APP (fAPP) with molecular weight in kDA (A). Protein levels 
were higher in female 5XFAD compared to male transgenic animals in both the soluble (B) and 
insoluble (C) fractions. All data were normalised to female WT with data sets visualised as scatter 
plots with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as 
****=p<0.0001, **=p<0.01 (Bonferroni post-hoc test). 
Fig. 7: Heightened MOAB-2 levels in female 5XFAD mice compared to male 5XFAD mice in soluble 
but not insoluble fractions: Representative images of dot blots of both soluble and insoluble 
fractions probed with MOAB-2 for the detection of Aβ (A). Protein levels were higher in female 
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5XFAD animals compared to male transgenic animals in soluble (B) but not insoluble (C) fraction. All 
data were normalised to female WT and visualised as scatter plots with mean ± SD; tables indicate 
significant 2-way ANOVA effects where int=interaction, gen=genotype; significances for individual 
genotypes/sexes are displayed on graph as ****=p<0.0001, ***=p<0.001, **=p<0.01 (Bonferroni 
post-hoc test).  
Fig. 8: Inflammation was enhanced in 5XFAD mice: Representative images of western blots for 
GFAP and Iba-1 with corresponding molecular weights in kDa (A). Group average protein levels for 
GFAP (B), Iba-1 (C), and gene expression of NLRP3 (D) were higher in female 5XFAD animals 
compared to their corresponding WT and compared to the male 5XFAD (for Iba-1 and NLRP3). All 
data were normalised to female WT and visualised as scatter plots with mean ± SD; tables indicate 
significant 2-way ANOVA effects where int=interaction, gen=genotype; significances for individual 
genotypes/sexes are displayed on graph as, ***=p<0.001, **=p<0.01, *=p<0.05 (Bonferroni post-hoc 
test).  
Fig. 9: No major changes in pre- and post-synaptic markers: Representative images of Western 
blots for synaptophysin and PSD-95 with corresponding molecular weights in kDa (A).  A subtle sex 
effect (but no effect of genotype) was noted for synaptophysin such that females had heightened 
levels of this presynaptic protein (B). Protein levels of PSD-95 were higher in 5XFAD animals only 
relative to their WT (C). All data were normalised to female WT and are presented as scatter plots 
with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as *=p<0.05 
(Bonferroni post-hoc test). 
Fig. 10: Heightened expression of HSP-related markers in male mice: Gene expression of ER stress 
markers BiP (A), Hsp70 (B), and CHOP (C) were higher in male 5XFAD animals compared to female 
5XFAD. Male WT animals also had higher expression compared to female WT animals in case of BiP 
and CHOP. In addition, male WT had higher expression of ATF6 (D) and XBPt (F) compared to both 
male 5XFAD and female WT animals.  Female 5XFAD animals had very low expression of IRE1α 
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expression (E) compared to female WT and male 5XFAD (marginally significant) while neither XBPs 
(G) nor the ratio of XBPs/XBPt (H) revealed any differences. All data are presented as scatter plots 
with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as, 
****=p<0.0001, *=p<0.05 (Bonferroni post-hoc test).  
Fig. 11: Heightened neurotrophic factor expression in male mice: Gene expression of neurotrophic 
factors revealed no genotypic or sex differences in BDNF (A). CREB (B) was higher in male 5XFAD (or 
WT) compared to female 5XFAD (or WT) but TrkB was found to be higher in male WT compared to 
female WT as well as male 5XFAD animals (C). Data are presented as scatter plots with mean ± SD; 
tables indicate significant 2-way ANOVA effects where int=interaction, gen=genotype; significances 
for individual genotypes/sexes are displayed on graph as ***=p<0.001, **=p<0.01, *=p<0.05 
(Bonferroni post-hoc test). 
Fig. 12: Correlations matrices between behavioural and molecular markers: Heat plots depict Z-score 
converted (overall mean) correlation matrices with positive (blue) and negative (red) correlations 
based on Pearson’s r correlational coefficient, for WT ♀+♂ (A) and (B) 5XFAD ♀+♂ animals. 
Behavioural and tissue markers are placed in sequence of their examination. Upper and lower triangle 
represent mirror images and dashed lines denote proxy categories (behavioural, pathology and 
inflammation, stress and trophic support. Abbreviations utilised are as follows: Activity OF/NO/SI= 
total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall zone during OF; Time 
zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); Visits NO/SI= Total 
number of visits during NO (NO1+NO2)/SI(SI1+SI2); Exploration NO/SI= Total time in directed 
exploration during NO (NO1+NO2)/SI (SI1+SI2); Sol. = Soluble ; insol.= insoluble; Path/infl= 
pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or inflammatory 
pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by markers belonging to 
ER stress/neurotrophic pathways. For further detail, see Results. 
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SUPPLEMENTARY TABLE S1 
COMPLETE RESULTS OF 3-WAY ANOVA FOR OF-NO-SI  
OPEN FIELD 
ACTIVITY IN THE OPEN FIELD (see Figure 2a for the significant results, 
graphs and 2c for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 182.0 P<0.0001 
Sex F (1, 34) = 2.853 P=0.1003 
Genotype F (1, 34) = 18.93 P=0.0001 
Trial x Sex F (1, 34) = 3.431 P=0.0727 
Trial x Genotype F (1, 34) = 0.4296 P=0.5166 
Sex x Genotype F (1, 34) = 0.1267 P=0.7241 
Trial x Sex x Genotype F (1, 34) = 15.06 P=0.0005 
 
TIME IN WALL ZONE (see Figure 2b for the significant results and 
graphs and 2c for heatmaps)  
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 46.92 P<0.0001 
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Sex F (1, 34) = 5.406 P=0.0262 
Genotype F (1, 34) = 1.947 P=0.1720 
Trial x Sex F (1, 34) = 0.007340 P=0.9322 
Trial x Genotype F (1, 34) = 1.180 P=0.2851 
Sex x Genotype F (1, 34) = 6.190 P=0.0179 
Trial x Sex x Genotype F (1, 34) = 0.0006814 P=0.9793 
 
NOVEL OBJECT 
NO: TIME IN ZONE (see Figure 3a for the significant results, graphs 
and 3d for the heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 15.14 P=0.0004 
Sex F (1, 34) = 8.759 P=0.0056 
Genotype F (1, 34) = 0.5173 P=0.4769 
Trial x Sex F (1, 34) = 2.232 P=0.1444 
Trial x Genotype F (1, 34) = 0.8432 P=0.3649 
Sex x Genotype F (1, 34) = 3.980 P=0.0541 
Trial x Sex x Genotype F (1, 34) = 0.8274 P=0.3694 
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NO: NUMBER OF VISITS (see Figure 3b for the significant results, 
graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 232.2 P<0.0001 
Sex F (1, 34) = 0.4673 P=0.4989 
Genotype F (1, 34) = 11.15 P=0.0020 
Trial x Sex F (1, 34) = 3.064 P=0.0891 
Trial x Genotype F (1, 34) = 2.042 P=0.1621 
Sex x Genotype F (1, 34) = 0.1969 P=0.6601 
Trial x Sex x Genotype F (1, 34) = 2.042 P=0.1621 
 
NO: DIRECTED EXPLORATION ((see Figure 3c for the significant 
results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 232.2 P<0.0001 
Sex F (1, 34) = 4.156 P=0.0493 
Genotype F (1, 34) = 1.627 P=0.2108 
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Trial x Sex F (1, 34) = 2.781 P=0.1045 
Trial x Genotype F (1, 34) = 0.1379 P=0.7126 
Sex x Genotype F (1, 34) = 0.0004 P=0.9840 
Trial x Sex x Genotype F (1, 34) = 0.9038 P=0.3485 
 
NO: OVERALL ACTIVITY (see Supplementary Figure S2A for significant 
results, graphs) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 317.9 P<0.0001 
Sex F (1, 34) = 1.314 P=0.2596 
Genotype F (1, 34) = 8.004 P=0.0078 
Trial x Sex F (1, 34) = 3.085 P=0.0880 
Trial x Genotype F (1, 34) = 3.420 P=0.0731 
Sex x Genotype F (1, 34) = 1.748 P=0.1949 
Trial x Sex x Genotype F (1, 34) = 1.444 P=0.2378 
 
SOCIAL INTERACTION 
SI: TIME IN ZONE (see Figure 4a for the significant results, graphs and 
4d for heatmaps) 
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3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 18.69 P=0.0001 
Sex F (1, 34) = 1.123 P=0.2967 
Genotype F (1, 34) = 7.386 P=0.0103 
Trial x Sex F (1, 34) = 0.1888 P=0.6667 
Trial x Genotype F (1, 34) = 0.4639 P=0.5004 
Sex x Genotype F (1, 34) = 0.2600 P=0.6134 
Trial x Sex x Genotype F (1, 34) = 2.323 P=0.1367 
 
SI: NO OF VISITS 
3-way ANOVA, with sex, genotype, trial (RM) as factors (see Figure 
4b for the significant results, graphs and 4d for heatmaps) 
Factor F value P-value 
Trial F (1, 34) = 1.180 P=0.2849 
Sex F (1, 34) = 0.4670 P=0.4990 
Genotype F (1, 34) = 6.299 P=0.0170 
Trial x Sex F (1, 34) = 0.4534 P=0.5053 
Trial x Genotype F (1, 34) = 1.682 P=0.2034 
Sex x Genotype F (1, 34) = 8.979 P=0.0051 
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Trial x Sex x Genotype F (1, 34) = 0.02226 P=0.8823 
 
SI: DIRECTED EXPLORATION (see Figure 44 for the significant results, 
graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 22.33 P<0.0001 
Sex F (1, 34) = 9.303 P=0.0044 
Genotype F (1, 34) = 0.890 P=0.3520 
Trial x Sex F (1, 34) = 2.452 P=0.9961 
Trial x Genotype F (1, 34) = 1.499 P=0.2292 
Sex x Genotype F (1, 34) = 0.3048 P=0.5845 
Trial x Sex x Genotype F (1, 34) = 0.1162 P=0.7353 
 
SI: OVERALL ACTIVITY (see Supplementary Figure S2B for significant 
results, graphs) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 30.06 P<0.0001 
Sex F (1, 34) = 3.393 P=0.0742 
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Genotype F (1, 34) = 1.365 P=0.2508 
Trial x Sex F (1, 34) = 6.665 P=0.0143 
Trial x Genotype F (1, 34) = 1.772 P=0.1920 
Sex x Genotype F (1, 34) = 3.057 P=0.0894 




SUPPLEMENTARY TABLE S2 
SIGNIFICANT RESULTS OF POST-HOC MULTIPLE COMPARISON’S 
(BONFERRONI’S) FOR OF-NO-SI  
OF: Activity 
Factors P-value 
OF1:Female WT vs. OF2:Female WT <0.0001 
OF1:Female 5XFAD vs. OF2:Female 5XFAD 0.0176 
OF1:Male WT vs. OF2:Male WT <0.0001 
OF1:Male 5XFAD vs. OF2:Male 5XFAD <0.0001 
OF1:Male WT vs. OF1:Male 5XFAD 0.01 
OF2:Female WT vs. OF2:Female 5XFAD 0.0013 
OF1:Female 5XFAD vs. OF1:Male 5XFAD 0.0817 
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OF1:Female WT vs. OF1:Male 5XFAD 0.0027 
OF1:Female WT vs. OF2:Male WT 0.0174 
OF1:Female 5XFAD vs. OF2:Female WT <0.0001 
OF1:Female 5XFAD vs. OF2:Male WT 0.0001 
OF1:Female 5XFAD vs. OF2:Male 5XFAD 0.0179 
OF1:Male WT vs. OF2:Female WT <0.0001 
OF1:Male 5XFAD vs. OF2:Female WT <0.0001 
OF1:Male 5XFAD vs. OF2:Female 5XFAD <0.0001 
OF1:Male 5XFAD vs. OF2:Male WT <0.0001 
OF2:Female WT vs. OF2:Male 5XFAD 0.0401 
 
OF: Time in wall zone  
Factors P-value 
Female 5XFAD vs. Female WT 0.025 






NO: Time in zone 
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Factors P-value 




NO1: WT vs. 5XFAD   0.004 
NO1 vs. NO2: WT <0.0001 
NO1 vs. NO2: 5XFAD <0.0001 
  
SI: Number of visits 
Factors           P-value 
    Female 5XFAD vs. Female WT 0.0001 




 SI: Activity 
Factors P-value 
Female: SI1 vs SI2 <0.0001 
SI1: Female vs Male 0.022 
 
SUPPLEMENTARY FIGURE LEGENDS 
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Fig. S1: Locomotor activity in the open field trials (OF1 and OF2): Time course of distance traversed 
(in meters, m) during OF1 and OF2 trials for female (♀) (A) and male (♂) 5XFAD vs WT mice (B). All 
data are group means +/- SD, with statistical outcomes of 2-way ANOVA with trial and time as 
repeated measures for each sex/genotype indicated below. Significances are indicated as: ***=p 
<0.001, **=p<0.01, *=p<0.05 (see methods for further details about the 2-way ANOVAs). 
Fig. S2: Overall activity measures during NO and SI: Total distance traversed (in meters, m, per trial) 
during NO (A) and SI (B) trials for female and male 5XFAD vs WT mice. Tables below graphs indicate 
statistically significant outcomes from a 3-way ANOVA with sex, genotype and trial (repeated 
measures) as factors. Full statistical details can be found in Suppl. 1. All data are group means +/- SD, 
Significances are indicated as: ****=p <0.0001, ***= p<0.001, **=p<0.01, *=p<0.05. 
Fig. S3: Familiarity index for time in zone, number of visits and directed exploration during trials: 
Familiarity indices in the form of scatter plots for time in zone, number of visits and directed 
exploration during NO (A, B and C, respectively); SI (D, E and F, respectively) and NO vs SI (G, H, and I, 
respectively) for female and male 5XFAD and WT mice. Results of one-sample t-tests for each group 
(against chance), and significances (or lack of) are indicated above the bars. No group difference using 
a one-way ANOVA was observed. Table below graph in G indicates statistically significant outcomes 
from a 3-way ANOVA with sex, genotype and trial (repeated measures, NO vs SI) as factors. Data are 
presented as group means ± SD with symbols representing individuals; significances are indicated as: 
****=p <0.0001, ***= p<0.001, *=p<0.05, ns=not significant. 
Fig. S4: Coomassie loading controls: Example images of Coomassie total protein-stained nitrocellulose 
membranes, relating to examples of ECL images of western blots provided in main manuscript. 
Densitometric measurements were taken from each lane for normalisation of ECL measures specific 
to target protein.  Note that some membranes were used for the detection of more than one antigen 
(PSD-95 and GFAP) whereas Ponceau was used for the normalisation of Iba-1 as Coomassie did not 
bind very well to the membrane.  
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Fig. S5: Correlations matrices between behavioural and molecular markers with values of 
correlational coefficients (r) and p-values indicated: Heat plots depict Z-score converted (overall 
mean) correlation matrices with values of the Pearson’s correlational coefficients (positive (blue) and 
negative (red)) indicated within each of the matrices on the left for WT  +  (A)and 5XFAD  +   (C) 
animals and p-values on the right (<0.06) for WT  +   (B)and 5XFAD  +  (D), respectively. 
Behavioural and tissue markers are placed in sequence of their examination. Upper and lower triangle 
represent mirror images and dashed lines denote proxy categories (behavioural, pathology and 
inflammation, stress and trophic support. Abbreviations utilised are as follows: Activity OF/NO/SI= 
total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall zone during OF; Time 
zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); Visits NO/SI= Total 
number of visits during NO (NO1+NO2)/SI(SI1+SI2);Exploration NO/SI= Total time spent in directed 
exploration during NO (NO1+NO2)/ SI(SI1+SI2); Sol. = Soluble ; insol.= insoluble; Path/infl= 
pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or inflammatory 
pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by markers belonging to 
ER stress/neurotrophic pathways. For further detail, see Results. 
Fig. S6: Correlations matrices between behavioural and molecular markers with values of 
correlational coefficients (r) indicated for each sex/genotype group: Heat plots depict Z-score 
converted (overall mean) correlation matrices with Pearson’s correlational coefficients (positive (blue) 
and negative (red)) for WT   (A), WT  (B), 5XFAD   (C) and 5XFAD   (D) animals, respectively. 
Behavioural and tissue markers are placed in sequence of their examination. Upper and lower triangle 
represent mirror images and dashed lines denote proxy categories (behavioural, pathology and 
inflammation, stress and trophic support. Abbreviations utilised are as follows: Activity OF/NO/SI= 
total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall zone during OF; Time 
zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); Visits NO/SI= Total 
number of visits during NO (NO1+NO2)/SI(SI1+SI2);Exploration NO/SI= Total time spent in directed 
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exploration during NO (NO1+NO2)/ SI(SI1+SI2); Sol. = Soluble ; insol.= insoluble; Path/infl= 
pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or inflammatory 
pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by markers belonging to 
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FIGURE LEGENDS 
Fig. 1: The OF-NO-SI experimental design: OF-NO-SI consists of a circular Perspex arena first used as 
an open field (OF) (A). Next, a cylinder is placed in the centre of the arena (novel object trials, NO) 
and finally a stranger mouse was introduced into the cylinder for social interaction trials (SI). (B) An 
overview summary of a single run of the OF-NO-SI experiment: green boxes depict inter-trial 
intervals (ITIs, 15-minutes), during which a second animal can be interspersed. (C) An outline of 
borders and zones used for the parameters examined:  The ‘wall zone’ (5cm from the outer wall) and 
‘interaction zone’ (5cm from the cylinder) are indicated. 
Fig 2: Activity measures for the open field trials (OF1 and OF2): Total distance travelled (in meters, 
m, per trial) during OF1 and OF2 trials for female and male 5XFAD vs WT mice (A), and total time 
spent in the thigmotaxis zone (in seconds, s) (B). Tables below graphs indicate statistically significant 
outcomes from a 3-way ANOVA with sex, genotype and trial (repeated measures) as factors. The 
pattern of exploratory behaviour for each group is also illustrated by representative heatmaps of 
one individual animal belonging to each group where bright colours indicate locations of frequent 
visits and darker colours indicate areas of rare approaches during OF1 and OF2 (C). Full statistical 
details can be found in Suppl. 1. All data are group means ±SD, Significances are indicated as: ****=p 
<0.0001, ***= p<0.001, *=p<0.05. 
Fig. 3: Exploration of the novel object during NO1 and NO2: Total time in the exploration zone (in 
seconds, s, per trial) during NO1 and NO2 for female and male 5XFAD vs WT mice (A), total time in 
directed exploration of the novel object (in seconds, s, per trial) (B) and total number of visits to this 
zone (C). Tables below graphs indicate statistically significant outcomes from a 3-way ANOVA with sex, 
genotype and trial (repeated measures) as factors. Representative heatmaps for exploratory activity 
during NO trials (D) clearly reveal how pattern of exploratory activity has shifted to the novel object 
zone during these trials (brighter colour concentrated around the centre where object was placed). 
Full statistical details can be found in Suppl. 1. Data are presented as group means ± SD with symbols 
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representing individuals; significances are indicated as: ****=p <0.0001, ***= p<0.001, *=p<0.05, 
ns=not significant.  
Fig. 4: Exploration of the conspecific during SI1 and SI2: Total time in the exploration zone (in seconds, 
s, per trial) during SI1 and SI2 for female and male 5XFAD vs WT mice (A) total time in directed 
exploration of the novel object (in seconds, s, per trial) (B) and total number of visits to the zone (C). 
Tables below graphs indicate statistically significant outcomes from a 3-way ANOVA with sex, 
genotype and trial (repeated measures) as factors. Heatmaps for exploratory activity (brighter colour 
marks more frequent visits) during SI trials (D) are displayed. Full statistical details can be found in 
Suppl. 1. Data are presented as group means ± SD, Significances are indicated as: ****=p <0.0001, 
***= p<0.001, *=p<0.05, ns=not significant.  
Fig. 5: Gene expression of hAPP, but not PSEN-1 is higher in female 5XFAD animals compared to 
male transgenic mice: Gene expression of hAPP (A) and PSEN-1 (B) for 5XFAD animals of both sexes 
are reported as ratio of Ct values of most stable reference gene on plate (y-whazz/b-actin) with gene 
of interest (hAPP/hPSEN-1). Data are illustrated as scatter plots with mean ±SD; significance is 
displayed as: *=p<0.05 (parametric t-test), n=6.  
Fig. 6: Greater levels of full-length APP in female 5XFAD mice in soluble and insoluble fractions: 
Representative images of western blots of both soluble and insoluble fractions probed with antibody 
6E10 for the detection of full-length APP (fAPP) with molecular weight in kDA (A). Protein levels 
were higher in female 5XFAD compared to male transgenic animals in both the soluble (B) and 
insoluble (C) fractions. All data were normalised to female WT with data sets visualised as scatter 
plots with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as 
****=p<0.0001, **=p<0.01 (Bonferroni post-hoc test). 
Fig. 7: Heightened MOAB-2 levels in female 5XFAD mice compared to male 5XFAD mice in soluble 
but not insoluble fractions: Representative images of dot blots of both soluble and insoluble 
fractions probed with MOAB-2 for the detection of Aβ (A). Protein levels were higher in female 
Sil et al., 2021: Sex difference in 5X mice 
5XFAD animals compared to male transgenic animals in soluble (B) but not insoluble (C) fraction. All 
data were normalised to female WT and visualised as scatter plots with mean ± SD; tables indicate 
significant 2-way ANOVA effects where int=interaction, gen=genotype; significances for individual 
genotypes/sexes are displayed on graph as ****=p<0.0001, ***=p<0.001, **=p<0.01 (Bonferroni 
post-hoc test).  
Fig. 8: Inflammation was enhanced in 5XFAD mice: Representative images of western blots for 
GFAP and Iba-1 with corresponding molecular weights in kDa (A). Group average protein levels for 
GFAP (B), Iba-1 (C), and gene expression of NLRP3 (D) were higher in female 5XFAD animals 
compared to their corresponding WT and compared to the male 5XFAD (for Iba-1 and NLRP3). All 
data were normalised to female WT and visualised as scatter plots with mean ± SD; tables indicate 
significant 2-way ANOVA effects where int=interaction, gen=genotype; significances for individual 
genotypes/sexes are displayed on graph as, ***=p<0.001, **=p<0.01, *=p<0.05 (Bonferroni post-hoc 
test).  
Fig. 9: No major changes in pre- and post-synaptic markers: Representative images of Western 
blots for synaptophysin and PSD-95 with corresponding molecular weights in kDa (A).  A subtle sex 
effect (but no effect of genotype) was noted for synaptophysin such that females had heightened 
levels of this presynaptic protein (B). Protein levels of PSD-95 were higher in 5XFAD animals only 
relative to their WT (C). All data were normalised to female WT and are presented as scatter plots 
with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as *=p<0.05 
(Bonferroni post-hoc test). 
Fig. 10: Heightened expression of HSP-related markers in male mice: Gene expression of ER stress 
markers BiP (A), Hsp70 (B), and CHOP (C) were higher in male 5XFAD animals compared to female 
5XFAD. Male WT animals also had higher expression compared to female WT animals in case of BiP 
and CHOP. In addition, male WT had higher expression of ATF6 (D) and XBPt (F) compared to both 
male 5XFAD and female WT animals.  Female 5XFAD animals had very low expression of IRE1α 
Sil et al., 2021: Sex difference in 5X mice 
expression (E) compared to female WT and male 5XFAD (marginally significant) while neither XBPs 
(G) nor the ratio of XBPs/XBPt (H) revealed any differences. All data are presented as scatter plots 
with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as, 
****=p<0.0001, *=p<0.05 (Bonferroni post-hoc test).  
Fig. 11: Heightened neurotrophic factor expression in male mice: Gene expression of neurotrophic 
factors revealed no genotypic or sex differences in BDNF (A). CREB (B) was higher in male 5XFAD (or 
WT) compared to female 5XFAD (or WT) but TrkB was found to be higher in male WT compared to 
female WT as well as male 5XFAD animals (C). Data are presented as scatter plots with mean ± SD; 
tables indicate significant 2-way ANOVA effects where int=interaction, gen=genotype; significances 
for individual genotypes/sexes are displayed on graph as ***=p<0.001, **=p<0.01, *=p<0.05 
(Bonferroni post-hoc test). 
Fig. 12: Correlations matrices between behavioural and molecular markers: Heat plots depict Z-score 
converted (overall mean) correlation matrices with positive (blue) and negative (red) correlations 
based on Pearson’s r correlational coefficient, for WT ♀+♂ (A) and (B) 5XFAD ♀+♂ animals. 
Behavioural and tissue markers are placed in sequence of their examination. Upper and lower triangle 
represent mirror images and dashed lines denote proxy categories (behavioural, pathology and 
inflammation, stress and trophic support. Abbreviations utilised are as follows: Activity OF/NO/SI= 
total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall zone during OF; Time 
zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); Visits NO/SI= Total 
number of visits during NO (NO1+NO2)/SI(SI1+SI2); Exploration NO/SI= Total time in directed 
exploration during NO (NO1+NO2)/SI (SI1+SI2); Sol. = Soluble ; insol.= insoluble; Path/infl= 
pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or inflammatory 
pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by markers belonging to 
ER stress/neurotrophic pathways. For further detail, see Results. 
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SUPPLEMENTARY TABLE S1 
COMPLETE RESULTS OF 3-WAY ANOVA FOR OF-NO-SI  
OPEN FIELD 
ACTIVITY IN THE OPEN FIELD (see Figure 2a for the significant results, graphs and 2c for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 182.0 P<0.0001 
Sex F (1, 34) = 2.853 P=0.1003 
Genotype F (1, 34) = 18.93 P=0.0001 
Trial x Sex F (1, 34) = 3.431 P=0.0727 
Trial x Genotype F (1, 34) = 0.4296 P=0.5166 
Sex x Genotype F (1, 34) = 0.1267 P=0.7241 
Trial x Sex x Genotype F (1, 34) = 15.06 P=0.0005 
 
TIME IN WALL ZONE (see Figure 2b for the significant results and graphs and 2c for heatmaps)  
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 46.92 P<0.0001 
Sex F (1, 34) = 5.406 P=0.0262 
Genotype F (1, 34) = 1.947 P=0.1720 
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Trial x Sex F (1, 34) = 0.007340 P=0.9322 
Trial x Genotype F (1, 34) = 1.180 P=0.2851 
Sex x Genotype F (1, 34) = 6.190 P=0.0179 
Trial x Sex x Genotype F (1, 34) = 0.0006814 P=0.9793 
 
NOVEL OBJECT 
NO: TIME IN ZONE (see Figure 3a for the significant results, graphs and 3d for the heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 15.14 P=0.0004 
Sex F (1, 34) = 8.759 P=0.0056 
Genotype F (1, 34) = 0.5173 P=0.4769 
Trial x Sex F (1, 34) = 2.232 P=0.1444 
Trial x Genotype F (1, 34) = 0.8432 P=0.3649 
Sex x Genotype F (1, 34) = 3.980 P=0.0541 
Trial x Sex x Genotype F (1, 34) = 0.8274 P=0.3694 
 
 
NO: NUMBER OF VISITS (see Figure 3b for the significant results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
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Factor F value P-value 
Trial F (1, 34) = 232.2 P<0.0001 
Sex F (1, 34) = 0.4673 P=0.4989 
Genotype F (1, 34) = 11.15 P=0.0020 
Trial x Sex F (1, 34) = 3.064 P=0.0891 
Trial x Genotype F (1, 34) = 2.042 P=0.1621 
Sex x Genotype F (1, 34) = 0.1969 P=0.6601 
Trial x Sex x Genotype F (1, 34) = 2.042 P=0.1621 
 
NO: DIRECTED EXPLORATION ((see Figure 3c for the significant results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 232.2 P<0.0001 
Sex F (1, 34) = 4.156 P=0.0493 
Genotype F (1, 34) = 1.627 P=0.2108 
Trial x Sex F (1, 34) = 2.781 P=0.1045 
Trial x Genotype F (1, 34) = 0.1379 P=0.7126 
Sex x Genotype F (1, 34) = 0.0004 P=0.9840 
Trial x Sex x Genotype F (1, 34) = 0.9038 P=0.3485 
 
NO: OVERALL ACTIVITY (see Supplementary Figure S2A for significant results, graphs) 
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3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 317.9 P<0.0001 
Sex F (1, 34) = 1.314 P=0.2596 
Genotype F (1, 34) = 8.004 P=0.0078 
Trial x Sex F (1, 34) = 3.085 P=0.0880 
Trial x Genotype F (1, 34) = 3.420 P=0.0731 
Sex x Genotype F (1, 34) = 1.748 P=0.1949 
Trial x Sex x Genotype F (1, 34) = 1.444 P=0.2378 
 
SOCIAL INTERACTION 
SI: TIME IN ZONE (see Figure 4a for the significant results, graphs and 4d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 18.69 P=0.0001 
Sex F (1, 34) = 1.123 P=0.2967 
Genotype F (1, 34) = 7.386 P=0.0103 
Trial x Sex F (1, 34) = 0.1888 P=0.6667 
Trial x Genotype F (1, 34) = 0.4639 P=0.5004 
Sex x Genotype F (1, 34) = 0.2600 P=0.6134 
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Trial x Sex x Genotype F (1, 34) = 2.323 P=0.1367 
 
SI: NO OF VISITS 
3-way ANOVA, with sex, genotype, trial (RM) as factors (see Figure 4b for the significant results, 
graphs and 4d for heatmaps) 
Factor F value P-value 
Trial F (1, 34) = 1.180 P=0.2849 
Sex F (1, 34) = 0.4670 P=0.4990 
Genotype F (1, 34) = 6.299 P=0.0170 
Trial x Sex F (1, 34) = 0.4534 P=0.5053 
Trial x Genotype F (1, 34) = 1.682 P=0.2034 
Sex x Genotype F (1, 34) = 8.979 P=0.0051 
Trial x Sex x Genotype F (1, 34) = 0.02226 P=0.8823 
 
SI: DIRECTED EXPLORATION (see Figure 44 for the significant results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 22.33 P<0.0001 
Sex F (1, 34) = 9.303 P=0.0044 
Genotype F (1, 34) = 0.890 P=0.3520 
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Trial x Sex F (1, 34) = 2.452 P=0.9961 
Trial x Genotype F (1, 34) = 1.499 P=0.2292 
Sex x Genotype F (1, 34) = 0.3048 P=0.5845 
Trial x Sex x Genotype F (1, 34) = 0.1162 P=0.7353 
 
SI: OVERALL ACTIVITY (see Supplementary Figure S2B for significant results, graphs) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 30.06 P<0.0001 
Sex F (1, 34) = 3.393 P=0.0742 
Genotype F (1, 34) = 1.365 P=0.2508 
Trial x Sex F (1, 34) = 6.665 P=0.0143 
Trial x Genotype F (1, 34) = 1.772 P=0.1920 
Sex x Genotype F (1, 34) = 3.057 P=0.0894 




SUPPLEMENTARY TABLE S2 
SIGNIFICANT RESULTS OF POST-HOC MULTIPLE COMPARISON’S (BONFERRONI’S) FOR OF-NO-SI  
Sil et al., 2021: Sex difference in 5X mice 
OF: Activity 
Factors P-value 
OF1:Female WT vs. OF2:Female WT <0.0001 
OF1:Female 5XFAD vs. OF2:Female 5XFAD 0.0176 
OF1:Male WT vs. OF2:Male WT <0.0001 
OF1:Male 5XFAD vs. OF2:Male 5XFAD <0.0001 
OF1:Male WT vs. OF1:Male 5XFAD 0.01 
OF2:Female WT vs. OF2:Female 5XFAD 0.0013 
OF1:Female 5XFAD vs. OF1:Male 5XFAD 0.0817 
OF1:Female WT vs. OF1:Male 5XFAD 0.0027 
OF1:Female WT vs. OF2:Male WT 0.0174 
OF1:Female 5XFAD vs. OF2:Female WT <0.0001 
OF1:Female 5XFAD vs. OF2:Male WT 0.0001 
OF1:Female 5XFAD vs. OF2:Male 5XFAD 0.0179 
OF1:Male WT vs. OF2:Female WT <0.0001 
OF1:Male 5XFAD vs. OF2:Female WT <0.0001 
OF1:Male 5XFAD vs. OF2:Female 5XFAD <0.0001 
OF1:Male 5XFAD vs. OF2:Male WT <0.0001 
OF2:Female WT vs. OF2:Male 5XFAD 0.0401 
 
OF: Time in wall zone  
Factors P-value 
Female 5XFAD vs. Female WT 0.025 






NO: Time in zone 
Factors P-value 




NO1: WT vs. 5XFAD   0.004 
NO1 vs. NO2: WT <0.0001 
NO1 vs. NO2: 5XFAD <0.0001 
  
SI: Number of visits 
Factors           P-value 
    Female 5XFAD vs. Female WT 0.0001 




 SI: Activity 
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Factors P-value 
Female: SI1 vs SI2 <0.0001 
SI1: Female vs Male 0.022 
  
SUPPLEMENTARY FIGURE LEGENDS 
Fig. S1: Locomotor activity in the open field trials (OF1 and OF2): Time course of distance traversed 
(in meters, m) during OF1 and OF2 trials for female (♀) (A) and male (♂) 5XFAD vs WT mice (B). All 
data are group means +/- SD, with statistical outcomes of 2-way ANOVA with trial and time as 
repeated measures for each sex/genotype indicated below. Significances are indicated as: ***=p 
<0.001, **=p<0.01, *=p<0.05 (see methods for further details about the 2-way ANOVAs). 
Fig. S2: Overall activity measures during NO and SI: Total distance traversed (in meters, m, per trial) 
during NO (A) and SI (B) trials for female and male 5XFAD vs WT mice. Tables below graphs indicate 
statistically significant outcomes from a 3-way ANOVA with sex, genotype and trial (repeated 
measures) as factors. Full statistical details can be found in Suppl. 1. All data are group means +/- SD, 
Significances are indicated as: ****=p <0.0001, ***= p<0.001, **=p<0.01, *=p<0.05. 
Fig. S3: Familiarity index for time in zone, number of visits and directed exploration during trials: 
Familiarity indices in the form of scatter plots for time in zone, number of visits and directed 
exploration during NO (A, B and C, respectively); SI (D, E and F, respectively) and NO vs SI (G, H, and I, 
respectively) for female and male 5XFAD and WT mice. Results of one-sample t-tests for each group 
(against chance), and significances (or lack of) are indicated above the bars. No group difference using 
a one-way ANOVA was observed. Table below graph in G indicates statistically significant outcomes 
from a 3-way ANOVA with sex, genotype and trial (repeated measures, NO vs SI) as factors. Data are 
presented as group means ± SD with symbols representing individuals; significances are indicated as: 
****=p <0.0001, ***= p<0.001, *=p<0.05, ns=not significant. 
Fig. S4: Coomassie loading controls: Example images of Coomassie total protein-stained nitrocellulose 
membranes, relating to examples of ECL images of western blots provided in main manuscript. 
Densitometric measurements were taken from each lane for normalisation of ECL measures specific 
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to target protein.  Note that some membranes were used for the detection of more than one antigen 
(PSD-95 and GFAP) whereas Ponceau was used for the normalisation of Iba-1 as Coomassie did not 
bind very well to the membrane.  
Fig. S5: Correlations matrices between behavioural and molecular markers with values of 
correlational coefficients (r) and p-values indicated: Heat plots depict Z-score converted (overall 
mean) correlation matrices with values of the Pearson’s correlational coefficients (positive (blue) and 
negative (red)) indicated within each of the matrices on the left for WT  +  (A)and 5XFAD  +   (C) 
animals and p-values on the right (<0.06) for WT  +   (B)and 5XFAD  +  (D), respectively. 
Behavioural and tissue markers are placed in sequence of their examination. Upper and lower triangle 
represent mirror images and dashed lines denote proxy categories (behavioural, pathology and 
inflammation, stress and trophic support. Abbreviations utilised are as follows: Activity OF/NO/SI= 
total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall zone during OF; Time 
zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); Visits NO/SI= Total 
number of visits during NO (NO1+NO2)/SI(SI1+SI2);Exploration NO/SI= Total time spent in directed 
exploration during NO (NO1+NO2)/ SI(SI1+SI2); Sol. = Soluble ; insol.= insoluble; Path/infl= 
pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or inflammatory 
pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by markers belonging to 
ER stress/neurotrophic pathways. For further detail, see Results. 
Fig. S6: Correlations matrices between behavioural and molecular markers with values of 
correlational coefficients (r) indicated for each sex/genotype group: Heat plots depict Z-score 
converted (overall mean) correlation matrices with Pearson’s correlational coefficients (positive (blue) 
and negative (red)) for WT   (A), WT  (B), 5XFAD   (C) and 5XFAD   (D) animals, respectively. 
Behavioural and tissue markers are placed in sequence of their examination. Upper and lower triangle 
represent mirror images and dashed lines denote proxy categories (behavioural, pathology and 
inflammation, stress and trophic support. Abbreviations utilised are as follows: Activity OF/NO/SI= 
Sil et al., 2021: Sex difference in 5X mice 
total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall zone during OF; Time 
zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); Visits NO/SI= Total 
number of visits during NO (NO1+NO2)/SI(SI1+SI2);Exploration NO/SI= Total time spent in directed 
exploration during NO (NO1+NO2)/ SI(SI1+SI2); Sol. = Soluble ; insol.= insoluble; Path/infl= 
pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or inflammatory 
pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by markers belonging to 
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FIGURE LEGENDS 
Fig. 1: The OF-NO-SI experimental design: OF-NO-SI consists of a circular Perspex arena first used as 
an open field (OF) (A). Next, a cylinder is placed in the centre of the arena (novel object trials, NO) 
and finally a stranger mouse was introduced into the cylinder for social interaction trials (SI). (B) An 
overview summary of a single run of the OF-NO-SI experiment: green boxes depict inter-trial 
intervals (ITIs, 15-minutes), during which a second animal can be interspersed. (C) An outline of 
borders and zones used for the parameters examined:  The ‘wall zone’ (5cm from the outer wall) and 
‘interaction zone’ (5cm from the cylinder) are indicated. 
Fig 2: Activity measures for the open field trials (OF1 and OF2): Total distance travelled (in meters, 
m, per trial) during OF1 and OF2 trials for female and male 5XFAD vs WT mice (A), and total time 
spent in the thigmotaxis zone (in seconds, s) (B). Tables below graphs indicate statistically significant 
outcomes from a 3-way ANOVA with sex, genotype and trial (repeated measures) as factors. The 
pattern of exploratory behaviour for each group is also illustrated by representative heatmaps of 
one individual animal belonging to each group where bright colours indicate locations of frequent 
visits and darker colours indicate areas of rare approaches during OF1 and OF2 (C). Full statistical 
details can be found in Suppl. 1. All data are group means ±SD, Significances are indicated as: ****=p 
<0.0001, ***= p<0.001, *=p<0.05. 
Fig. 3: Exploration of the novel object during NO1 and NO2: Total time in the exploration zone (in 
seconds, s, per trial) during NO1 and NO2 for female and male 5XFAD vs WT mice (A), total time in 
directed exploration of the novel object (in seconds, s, per trial) (B) and total number of visits to this 
zone (C). Tables below graphs indicate statistically significant outcomes from a 3-way ANOVA with 
sex, genotype and trial (repeated measures) as factors. Representative heatmaps for exploratory 
activity during NO trials (D) clearly reveal how pattern of exploratory activity has shifted to the novel 
object zone during these trials (brighter colour concentrated around the centre where object was 
placed). Full statistical details can be found in Suppl. 1. Data are presented as group means ± SD with 
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symbols representing individuals; significances are indicated as: ****=p <0.0001, ***= p<0.001, 
*=p<0.05, ns=not significant.  
Fig. 4: Exploration of the conspecific during SI1 and SI2: Total time in the exploration zone (in 
seconds, s, per trial) during SI1 and SI2 for female and male 5XFAD vs WT mice (A) total time in 
directed exploration of the novel object (in seconds, s, per trial) (B) and total number of visits to the 
zone (C). Tables below graphs indicate statistically significant outcomes from a 3-way ANOVA with 
sex, genotype and trial (repeated measures) as factors. Heatmaps for exploratory activity (brighter 
colour marks more frequent visits) during SI trials (D) are displayed. Full statistical details can be 
found in Suppl. 1. Data are presented as group means ± SD, Significances are indicated as: ****=p 
<0.0001, ***= p<0.001, *=p<0.05, ns=not significant.  
Fig. 5: Gene expression of hAPP, but not PSEN-1 is higher in female 5XFAD animals compared to 
male transgenic mice: Gene expression of hAPP (A) and PSEN-1 (B) for 5XFAD animals of both sexes 
are reported as ratio of Ct values of most stable reference gene on plate (y-whazz/b-actin) with gene 
of interest (hAPP/hPSEN-1). Data are illustrated as scatter plots with mean ±SD; significance is 
displayed as: *=p<0.05 (parametric t-test), n=6.  
Fig. 6: Greater levels of full-length APP in female 5XFAD mice in soluble and insoluble fractions: 
Representative images of western blots of both soluble and insoluble fractions probed with antibody 
6E10 for the detection of full-length APP (fAPP) with molecular weight in kDA (A). Protein levels 
were higher in female 5XFAD compared to male transgenic animals in both the soluble (B) and 
insoluble (C) fractions. All data were normalised to female WT with data sets visualised as scatter 
plots with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as 
****=p<0.0001, **=p<0.01 (Bonferroni post-hoc test). 
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Fig. 7: Heightened MOAB-2 levels in female 5XFAD mice compared to male 5XFAD mice in soluble 
but not insoluble fractions: Representative images of dot blots of both soluble and insoluble 
fractions probed with MOAB-2 for the detection of Aβ (A). Protein levels were higher in female 
5XFAD animals compared to male transgenic animals in soluble (B) but not insoluble (C) fraction. All 
data were normalised to female WT and visualised as scatter plots with mean ± SD; tables indicate 
significant 2-way ANOVA effects where int=interaction, gen=genotype; significances for individual 
genotypes/sexes are displayed on graph as ****=p<0.0001, ***=p<0.001, **=p<0.01 (Bonferroni 
post-hoc test).  
Fig. 8: Inflammation was enhanced in 5XFAD mice: Representative images of western blots for 
GFAP and Iba-1 with corresponding molecular weights in kDa (A). Group average protein levels for 
GFAP (B), Iba-1 (C), and gene expression of NLRP3 (D) were higher in female 5XFAD animals 
compared to their corresponding WT and compared to the male 5XFAD (for Iba-1 and NLRP3). All 
data were normalised to female WT and visualised as scatter plots with mean ± SD; tables indicate 
significant 2-way ANOVA effects where int=interaction, gen=genotype; significances for individual 
genotypes/sexes are displayed on graph as, ***=p<0.001, **=p<0.01, *=p<0.05 (Bonferroni post-hoc 
test).  
Fig. 9: No major changes in pre- and post-synaptic markers: Representative images of Western 
blots for synaptophysin and PSD-95 with corresponding molecular weights in kDa (A).  A subtle sex 
effect (but no effect of genotype) was noted for synaptophysin such that females had heightened 
levels of this presynaptic protein (B). Protein levels of PSD-95 were higher in 5XFAD animals only 
relative to their WT (C). All data were normalised to female WT and are presented as scatter plots 
with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as *=p<0.05 
(Bonferroni post-hoc test). 
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Fig. 10: Heightened expression of HSP-related markers in male mice: Gene expression of ER stress 
markers BiP (A), Hsp70 (B), and CHOP (C) were higher in male 5XFAD animals compared to female 
5XFAD. Male WT animals also had higher expression compared to female WT animals in case of BiP 
and CHOP. In addition, male WT had higher expression of ATF6 (D) and XBPt (F) compared to both 
male 5XFAD and female WT animals.  Female 5XFAD animals had very low expression of IRE1α 
expression (E) compared to female WT and male 5XFAD (marginally significant) while neither XBPs 
(G) nor the ratio of XBPs/XBPt (H) revealed any differences. All data are presented as scatter plots 
with mean ± SD; tables indicate significant 2-way ANOVA effects where int=interaction, 
gen=genotype; significances for individual genotypes/sexes are displayed on graph as, 
****=p<0.0001, *=p<0.05 (Bonferroni post-hoc test).  
Fig. 11: Heightened neurotrophic factor expression in male mice: Gene expression of neurotrophic 
factors revealed no genotypic or sex differences in BDNF (A). CREB (B) was higher in male 5XFAD (or 
WT) compared to female 5XFAD (or WT) but TrkB was found to be higher in male WT compared to 
female WT as well as male 5XFAD animals (C). Data are presented as scatter plots with mean ± SD; 
tables indicate significant 2-way ANOVA effects where int=interaction, gen=genotype; significances 
for individual genotypes/sexes are displayed on graph as ***=p<0.001, **=p<0.01, *=p<0.05 
(Bonferroni post-hoc test). 
Fig. 12: Correlations matrices between behavioural and molecular markers: Heat plots depict Z-
score converted (overall mean) correlation matrices with positive (blue) and negative (red) 
correlations based on Pearson’s r correlational coefficient, for WT  +   (A) and (B) 5XFAD  +   
animals. Behavioural and tissue markers are placed in sequence of their examination. Upper and 
lower triangle represent mirror images and dashed lines denote proxy categories (behavioural, 
pathology and inflammation, stress and trophic support. Abbreviations utilised are as follows: 
Activity OF/NO/SI= total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall 
zone during OF; Time zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); 
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Visits NO/SI= Total number of visits during NO (NO1+NO2)/SI(SI1+SI2); Exploration NO/SI= Total time 
in directed exploration during NO (NO1+NO2)/SI (SI1+SI2); Sol. = Soluble ; insol.= insoluble; 
Path/infl= pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or 
inflammatory pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by 
markers belonging to ER stress/neurotrophic pathways. For further detail, see Results. 
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SUPPLEMENTARY TABLE S1 
COMPLETE RESULTS OF 3-WAY ANOVA FOR OF-NO-SI  
OPEN FIELD 
ACTIVITY IN THE OPEN FIELD (see Figure 2a for the significant results, graphs and 2c for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 182.0 P<0.0001 
Sex F (1, 34) = 2.853 P=0.1003 
Genotype F (1, 34) = 18.93 P=0.0001 
Trial x Sex F (1, 34) = 3.431 P=0.0727 
Trial x Genotype F (1, 34) = 0.4296 P=0.5166 
Sex x Genotype F (1, 34) = 0.1267 P=0.7241 
Trial x Sex x Genotype F (1, 34) = 15.06 P=0.0005 
 
TIME IN WALL ZONE (see Figure 2b for the significant results and graphs and 2c for heatmaps)  
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 46.92 P<0.0001 
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Sex F (1, 34) = 5.406 P=0.0262 
Genotype F (1, 34) = 1.947 P=0.1720 
Trial x Sex F (1, 34) = 0.007340 P=0.9322 
Trial x Genotype F (1, 34) = 1.180 P=0.2851 
Sex x Genotype F (1, 34) = 6.190 P=0.0179 
Trial x Sex x Genotype F (1, 34) = 0.0006814 P=0.9793 
 
NOVEL OBJECT 
NO: TIME IN ZONE (see Figure 3a for the significant results, graphs and 3d for the heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 15.14 P=0.0004 
Sex F (1, 34) = 8.759 P=0.0056 
Genotype F (1, 34) = 0.5173 P=0.4769 
Trial x Sex F (1, 34) = 2.232 P=0.1444 
Trial x Genotype F (1, 34) = 0.8432 P=0.3649 
Sex x Genotype F (1, 34) = 3.980 P=0.0541 
Trial x Sex x Genotype F (1, 34) = 0.8274 P=0.3694 
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NO: NUMBER OF VISITS (see Figure 3b for the significant results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 232.2 P<0.0001 
Sex F (1, 34) = 0.4673 P=0.4989 
Genotype F (1, 34) = 11.15 P=0.0020 
Trial x Sex F (1, 34) = 3.064 P=0.0891 
Trial x Genotype F (1, 34) = 2.042 P=0.1621 
Sex x Genotype F (1, 34) = 0.1969 P=0.6601 
Trial x Sex x Genotype F (1, 34) = 2.042 P=0.1621 
 
NO: DIRECTED EXPLORATION ((see Figure 3c for the significant results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 232.2 P<0.0001 
Sex F (1, 34) = 4.156 P=0.0493 
Genotype F (1, 34) = 1.627 P=0.2108 
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Trial x Sex F (1, 34) = 2.781 P=0.1045 
Trial x Genotype F (1, 34) = 0.1379 P=0.7126 
Sex x Genotype F (1, 34) = 0.0004 P=0.9840 
Trial x Sex x Genotype F (1, 34) = 0.9038 P=0.3485 
 
NO: OVERALL ACTIVITY (see Supplementary Figure S2A for significant results, graphs) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 317.9 P<0.0001 
Sex F (1, 34) = 1.314 P=0.2596 
Genotype F (1, 34) = 8.004 P=0.0078 
Trial x Sex F (1, 34) = 3.085 P=0.0880 
Trial x Genotype F (1, 34) = 3.420 P=0.0731 
Sex x Genotype F (1, 34) = 1.748 P=0.1949 
Trial x Sex x Genotype F (1, 34) = 1.444 P=0.2378 
 
SOCIAL INTERACTION 
SI: TIME IN ZONE (see Figure 4a for the significant results, graphs and 4d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
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Factor F value P-value 
Trial F (1, 34) = 18.69 P=0.0001 
Sex F (1, 34) = 1.123 P=0.2967 
Genotype F (1, 34) = 7.386 P=0.0103 
Trial x Sex F (1, 34) = 0.1888 P=0.6667 
Trial x Genotype F (1, 34) = 0.4639 P=0.5004 
Sex x Genotype F (1, 34) = 0.2600 P=0.6134 
Trial x Sex x Genotype F (1, 34) = 2.323 P=0.1367 
 
SI: NO OF VISITS 
3-way ANOVA, with sex, genotype, trial (RM) as factors (see Figure 4b for the significant results, 
graphs and 4d for heatmaps) 
Factor F value P-value 
Trial F (1, 34) = 1.180 P=0.2849 
Sex F (1, 34) = 0.4670 P=0.4990 
Genotype F (1, 34) = 6.299 P=0.0170 
Trial x Sex F (1, 34) = 0.4534 P=0.5053 
Trial x Genotype F (1, 34) = 1.682 P=0.2034 
Sex x Genotype F (1, 34) = 8.979 P=0.0051 
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Trial x Sex x Genotype F (1, 34) = 0.02226 P=0.8823 
 
SI: DIRECTED EXPLORATION (see Figure 44 for the significant results, graphs and 3d for heatmaps) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 22.33 P<0.0001 
Sex F (1, 34) = 9.303 P=0.0044 
Genotype F (1, 34) = 0.890 P=0.3520 
Trial x Sex F (1, 34) = 2.452 P=0.9961 
Trial x Genotype F (1, 34) = 1.499 P=0.2292 
Sex x Genotype F (1, 34) = 0.3048 P=0.5845 
Trial x Sex x Genotype F (1, 34) = 0.1162 P=0.7353 
 
SI: OVERALL ACTIVITY (see Supplementary Figure S2B for significant results, graphs) 
3-way ANOVA, with sex, genotype, trial (RM) as factors 
Factor F value P-value 
Trial F (1, 34) = 30.06 P<0.0001 
Sex F (1, 34) = 3.393 P=0.0742 
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Genotype F (1, 34) = 1.365 P=0.2508 
Trial x Sex F (1, 34) = 6.665 P=0.0143 
Trial x Genotype F (1, 34) = 1.772 P=0.1920 
Sex x Genotype F (1, 34) = 3.057 P=0.0894 




SUPPLEMENTARY TABLE S2 
SIGNIFICANT RESULTS OF POST-HOC MULTIPLE COMPARISON’S (BONFERRONI’S) FOR OF-NO-SI  
OF: Activity 
Factors P-value 
OF1:Female WT vs. OF2:Female WT <0.0001 
OF1:Female 5XFAD vs. OF2:Female 5XFAD 0.0176 
OF1:Male WT vs. OF2:Male WT <0.0001 
OF1:Male 5XFAD vs. OF2:Male 5XFAD <0.0001 
OF1:Male WT vs. OF1:Male 5XFAD 0.01 
OF2:Female WT vs. OF2:Female 5XFAD 0.0013 
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OF1:Female 5XFAD vs. OF1:Male 5XFAD 0.0817 
OF1:Female WT vs. OF1:Male 5XFAD 0.0027 
OF1:Female WT vs. OF2:Male WT 0.0174 
OF1:Female 5XFAD vs. OF2:Female WT <0.0001 
OF1:Female 5XFAD vs. OF2:Male WT 0.0001 
OF1:Female 5XFAD vs. OF2:Male 5XFAD 0.0179 
OF1:Male WT vs. OF2:Female WT <0.0001 
OF1:Male 5XFAD vs. OF2:Female WT <0.0001 
OF1:Male 5XFAD vs. OF2:Female 5XFAD <0.0001 
OF1:Male 5XFAD vs. OF2:Male WT <0.0001 
OF2:Female WT vs. OF2:Male 5XFAD 0.0401 
 
OF: Time in wall zone  
Factors P-value 
Female 5XFAD vs. Female WT 0.025 
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NO: Time in zone 
Factors P-value 




NO1: WT vs. 5XFAD   0.004 
NO1 vs. NO2: WT <0.0001 
NO1 vs. NO2: 5XFAD <0.0001 
  
SI: Number of visits 
Factors           P-value 
    Female 5XFAD vs. Female WT 0.0001 
  Female 5XFAD vs. Male 5XFAD 0.0146 
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 SI: Activity 
Factors P-value 
Female: SI1 vs SI2 <0.0001 
SI1: Female vs Male 0.022 
  
SUPPLEMENTARY FIGURE LEGENDS 
Fig. S1: Locomotor activity in the open field trials (OF1 and OF2): Time course of distance traversed 
(in meters, m) during OF1 and OF2 trials for female (  ) (A) and male (  ) 5XFAD vs WT mice (B). All 
data are group means +/- SD, with statistical outcomes of 2-way ANOVA with trial and time as 
repeated measures for each sex/genotype indicated below. Significances are indicated as: ***=p 
<0.001, **=p<0.01, *=p<0.05 (see methods for further details about the 2-way ANOVAs). 
Fig. S2: Overall activity measures during NO and SI: Total distance traversed (in meters, m, per trial) 
during NO (A) and SI (B) trials for female and male 5XFAD vs WT mice. Tables below graphs indicate 
statistically significant outcomes from a 3-way ANOVA with sex, genotype and trial (repeated 
measures) as factors. Full statistical details can be found in Suppl. 1. All data are group means +/- SD, 
Significances are indicated as: ****=p <0.0001, ***= p<0.001, **=p<0.01, *=p<0.05. 
Fig. S3: Familiarity index for time in zone, number of visits and directed exploration during trials: 
Familiarity indices in the form of scatter plots for time in zone, number of visits and directed 
exploration during NO (A, B and C, respectively); SI (D, E and F, respectively) and NO vs SI (G, H, and 
I, respectively) for female and male 5XFAD and WT mice. Results of one-sample t-tests for each 
group (against chance), and significances (or lack of) are indicated above the bars. No group 
difference using a one-way ANOVA was observed. Table below graph in G indicates statistically 
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significant outcomes from a 3-way ANOVA with sex, genotype and trial (repeated measures, NO vs 
SI) as factors. Data are presented as group means ± SD with symbols representing individuals; 
significances are indicated as: ****=p <0.0001, ***= p<0.001, *=p<0.05, ns=not significant. 
Fig. S4: Coomassie loading controls: Example images of Coomassie total protein-stained 
nitrocellulose membranes, relating to examples of ECL images of western blots provided in main 
manuscript. Densitometric measurements were taken from each lane for normalisation of ECL 
measures specific to target protein.  Note that some membranes were used for the detection of 
more than one antigen (PSD-95 and GFAP) whereas Ponceau was used for the normalisation of Iba-1 
as Coomassie did not bind very well to the membrane.  
Fig. S5: Correlations matrices between behavioural and molecular markers with values of 
correlational coefficients (r) and p-values indicated: Heat plots depict Z-score converted (overall 
mean) correlation matrices with values of the Pearson’s correlational coefficients (positive (blue) 
and negative (red)) indicated within each of the matrices on the left for WT  + (A)and 5XFAD 
 +   (C) animals and p-values on the right (<0.06) for WT  +  (B)and 5XFAD  +   (D), 
respectively. Behavioural and tissue markers are placed in sequence of their examination. Upper and 
lower triangle represent mirror images and dashed lines denote proxy categories (behavioural, 
pathology and inflammation, stress and trophic support. Abbreviations utilised are as follows: 
Activity OF/NO/SI= total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall 
zone during OF; Time zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); 
Visits NO/SI= Total number of visits during NO (NO1+NO2)/SI(SI1+SI2);Exploration NO/SI= Total time 
spent in directed exploration during NO (NO1+NO2)/ SI(SI1+SI2); Sol. = Soluble ; insol.= insoluble; 
Path/infl= pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or 
inflammatory pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by 
markers belonging to ER stress/neurotrophic pathways. For further detail, see Results. 
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Fig. S6: Correlations matrices between behavioural and molecular markers with values of 
correlational coefficients (r) indicated for each sex/genotype group: Heat plots depict Z-score 
converted (overall mean) correlation matrices with Pearson’s correlational coefficients (positive 
(blue) and negative (red)) for WT   (A), WT  (B), 5XFAD   (C) and 5XFAD  (D) animals, 
respectively. Behavioural and tissue markers are placed in sequence of their examination. Upper and 
lower triangle represent mirror images and dashed lines denote proxy categories (behavioural, 
pathology and inflammation, stress and trophic support. Abbreviations utilised are as follows: 
Activity OF/NO/SI= total activity in OF1+OF2/NO1+NO2/SI1+SI2; wall zone OF= total time in wall 
zone during OF; Time zone NO/SI= total time in interaction zone during NO (NO1+NO2)/SI (SI1+SI2); 
Visits NO/SI= Total number of visits during NO (NO1+NO2)/SI(SI1+SI2);Exploration NO/SI= Total time 
spent in directed exploration during NO (NO1+NO2)/ SI(SI1+SI2); Sol. = Soluble ; insol.= insoluble; 
Path/infl= pathology/inflammation indicating clusters formed by markers for amyloid, synaptic or 
inflammatory pathways; Stress/Troph= ER stress, neurotrophic indicating clusters formed by 
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